.png)
COVID-19 Evidence Reviews
as of 7/30/21
= living review
= meets mimimum quality standards | A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
7/28/21
|
Ansari S, Chrantimath S | PROSPERO
|
|
|
7/28/21
|
Rajakumar S, Shamsuddin N, Nuri HZ | PROSPERO
|
|
|
7/28/21
|
Tilby M, Lennard L, Starkey T | PROSPERO
|
|
|
7/28/21
|
Ezezika O, Girmay B, Mengistu M, et al | PROSPERO
|
|
|
7/28/21
|
Mao J, Gao X, Yan P, et al. | BMJ Open
|
|
|
7/28/21
|
Pitaloka CP, Pakpahan C, Sulistyowati M, et al | PROSPERO
|
|
|
7/28/21
|
Ho E, Cong TX, YanHong D | PROSPERO
|
|
|
7/28/21
|
Liang M, Sun Y | PROSPERO
|
|
|
7/28/21
|
Oliaei S, Ahmed S, Alinaghi S, et al | PROSPERO
|
|
|
7/27/21
|
Theodoratou E, McQuillan R, Dozier M, et al | PROSPERO
|
|
|
7/27/21
|
Pei H, Wang Y, Zhang X, et al. | BMJ Open
|
|
|
7/27/21
|
Fernandes MR, Dala Rivas DFD, Nacif LS | PROSPERO
|
|
|
7/27/21
|
Babata K, Yeo KT, Chan C, et al | PROSPERO
|
|
|
7/27/21
|
Quintero C, Mesa D | PROSPERO
|
|
|
7/27/21
|
Lin CY, Lee MD | PROSPERO
|
|
|
7/27/21
|
De Diego-Cordero R, Ávila-Montilla A, Vega-Escaño J, et al | PROSPERO
|
|
|
7/27/21
|
Lin CY, Tai YL | PROSPERO
|
|
|
7/26/21
|
Octavius GS, Tan AO, Wijaya JH, et al | PROSPERO
|
|
|
7/26/21
|
Tenrisau D, Sudaryo MK | PROSPERO
|
|
|
7/26/21
|
Dai M, Xu H, Ge WH, et al | PROSPERO
|
|
|
7/26/21
|
Mishra A, Kh R, Maiti R | PROSPERO
|
|
|
7/26/21
|
Dhingra K, Paster B, Verma F, et al | PROSPERO
|
|
|
7/26/21
|
Arce Pardo S, Lai S, Ortiz-Muñoz L, et al. | Medwave
|
|
|
7/26/21
|
Min S, Ahn YM, Koo JW, et al | PROSPERO
|
|
|
7/26/21
|
Wolday D, Gebrecherkos T, Kiros YK, et al | PROSPERO
|
|
|
7/26/21
|
Endomba FT, Wouna DLA, Meli DLT | PROSPERO
|
|
|
7/26/21
|
Cui Y, Guo C, Wang J, et al | PROSPERO
|
|
|
7/26/21
|
Im J, Jin Y, Yan P, et al | PROSPERO
|
|
|
7/26/21
|
Bonnechere B, Feys P, Timmermans A, et al | PROSPERO
|
|
|
7/26/21
|
Damara F, Soetedjo NNM | PROSPERO
|
|
|
7/23/21
|
Molendijk ML, Molero P, Reina G, et al | PROSPERO
|
|
|
7/23/21
|
Jung JH, Kim K, Kim YH | PROSPERO
|
|
|
7/23/21
|
Zahmatyar M, Fazlollahi A | PROSPERO
|
|
|
7/23/21
|
Efficacy and safety of Chinese Medical treatment for COVID-19: a systematic review and meta analysis
Ji C, Wu H | PROSPERO
|
|
|
7/23/21
|
Gonella JM, Leclerc J, O'Connor S et al | PROSPERO
|
|
|
7/23/21
|
Sriwastava S, Wen S | PROSPERO
|
|
|
7/23/21
|
Martin E, Jennings E, Loughlin B, et al | PROSPERO
|
|
|
7/23/21
|
Almazrua AA, Brown T, Fischer JD, et al | PROSPERO
|
|
|
7/22/21
|
Leblebicioglu H, Ozaras R, Tutal E | PROSPERO
|
|
|
7/22/21
|
Kang X, Jin D, An X, et al | PROSPERO
|
|
|
7/22/21
|
Laganà AS, Sleiman Z | PROSPERO
|
|
|
7/22/21
|
Leblebicioglu H, Dilek A, Kaya T, et al | PROSPERO
|
|
|
7/22/21
|
Webster KE, MacKeith S, Philpott C, et al. | Cochrane Database Syst Rev
RECENTLY UPDATED
|
|
|
7/22/21
|
Duggal M, Verma P, Miglani V, et al | PROSPERO
|
|
|
7/22/21
|
Yusof RC, Noor NM, Yacob MA | PROSPERO
|
|
|
7/22/21
|
Qing X, Zhang Y | PROSPERO
|
|
|
7/21/21
|
Wang J, Sun Y, Cui Y, et al | PROSPERO
|
|
|
7/21/21
|
Xia T, Nie Y, Zhang C | PROSPERO
|
|
|
7/21/21
|
Chen CY, Chen WC, Hsu CK | PROSPERO
|
|
|
7/21/21
|
Espinoza C, Martella D | PROSPERO
|
|
|
7/21/21
|
Xie J, Mao N, Fan J | PROSPERO
|
|
|
7/21/21
|
de Carvalho F, Silva JP | PROSPERO
|
|
|
7/21/21
|
Leblebicioglu H, Ulu EMK, Dilek A | PROSPERO
|
|
|
7/21/21
|
Ding Y, Ding S, Niu J, et al. | Research Square
Aim: To assess the impact of coronavirus disease 2019 (COVID-19) on college students’ physical activity. RECENTLY UPDATED
|
|
|
7/20/21
|
Souza R, de Araújo J, de Aguiar R | PROSPERO
|
|
|
7/20/21
|
Quach HL, Hoang NA, Vogt F | PROSPERO
|
|
|
7/20/21
|
Tobias D, Speakman J | PROSPERO
|
|
|
7/20/21
|
Sobrinho RCS, de Meneses IR, Alves BC, et al | PROSPERO
|
|
|
7/20/21
|
Nawa N, Ishikawa N, Yamazaki J, et al | PROSPERO
|
|
|
7/20/21
|
Jia R, Liang D, Wu Z, et al | PROSPERO
|
|
|
7/20/21
|
Rao M, Zhang Y | PROSPERO
|
|
|
7/20/21
|
Jahrami H, Alhaj O, Humood A, et al | PROSPERO
|
|
|
7/20/21
|
Chen CH, Lai CC, Wang CY, et al | PROSPERO
|
|
|
7/20/21
|
Murali M, Jethwa H, Gumber L, et al | PROSPERO
|
|
|
7/19/21
|
Shrestha A, Budathoki P, Adhikari A, et al | PROSPERO
|
|
|
7/19/21
|
Boulos M, Jairim T, Jairim S, et al | PROSPERO
|
|
|
7/19/21
|
Liu J, Yan W | PROSPERO
|
|
|
7/19/21
|
Estrada M, Chacon P | PROSPERO
|
|
|
7/19/21
|
Pernambuco CS, Bezerra JCP, de Oliveira BBM, et al | PROSPERO
|
|
|
7/19/21
|
Arora K, Kukreja D, Gaunkar R, et al | PROSPERO
|
|
|
7/16/21
|
Fitzek A, Schadler J, Dietz E, et al. | Research Square
Aim: To classify all known SARS-CoV-2 associated deaths in the city of Hamburg, Germany, as COVID-19 or as non-COVID-19 deaths and to compare both groups, with respect to demographic, anthropometric and medical characteristics.
|
|
|
7/15/21
|
Davies R, Mowbray F, Smith L, et al | PROSPERO
|
|
|
7/15/21
|
Tariku M, Hajure M | PROSPERO
|
|
|
7/15/21
|
Dogheim G, Werida R, Ibrahim G, et al | PROSPERO
|
|
|
7/15/21
|
Costa P, Martins E | PROSPERO
|
|
|
7/15/21
|
Del Prato S, Penno G, Garofolo M | PROSPERO
|
|
|
7/15/21
|
Salmen-Navarro A, Lozada D, Friedman-Jimenez G, et al | PROSPERO
|
|
|
7/15/21
|
Maternal-fetal management and clinical manifestations due to COVID-19 infection: a systematic review
Bruce A, de Sousa P, Pontes EL, et al | PROSPERO
|
|
|
7/15/21
|
Jia R, Liang D, Wu Z, et al | PROSPERO
|
|
|
7/15/21
|
Wang J, Sun Y, Cui Y, et al | PROSPERO
|
|
|
7/15/21
|
Zheng X, Lu L, Tang C | PROSPERO
|
|
|
7/15/21
|
Kerdtawee P, Salang L, Sothornwit J | PROSPERO
|
|
|
7/15/21
|
Zuo Y, Chen Y, Li J, et al | PROSPERO
|
|
|
7/15/21
|
de Oliveira AA, Silva ASP, Mont'Alverne CG, et al | PROSPERO
|
|
|
7/15/21
|
Karki SJ, Lange B | PROSPERO
|
|
|
7/15/21
|
Czakert JP, dos Santos NR, Pais L, et al | PROSPERO
|
|
|
7/15/21
|
Floriano I, Silvinato A, Bernardo W | PROSPERO
|
|
|
7/15/21
|
Goodwin L, Iduye D, Hair K | PROSPERO
|
|
|
7/14/21
|
Mangoni A, Zinellu A | PROSPERO
|
|
|
7/14/21
|
Sun M, Xian J, Ang X, et al | PROSPERO
|
|
|
7/14/21
|
Georgakopoulou V, Damaskos C | PROSPERO
|
|
|
7/14/21
|
Rai AK, Ahmad A, Kumar V K, et al | PROSPERO
|
|
|
7/14/21
|
Ahmed W, Abdalla Y | PROSPERO
|
|
|
7/14/21
|
Endomba FT, Wouna DLA, Tiwa DML | PROSPERO
|
|
|
7/14/21
|
Yunusa A, Anderson E, Cabral C | PROSPERO
|
|
|
7/14/21
|
Mohamed K, Shafikhani P, Khajehamiri Y | PROSPERO
|
|
|
7/14/21
|
Arab-Zozanu M, Bahreini R | PROSPERO
|
|
|
7/14/21
|
Clapham K, Messum D, Robson D, et al | PROSPERO
|
|
|
7/13/21
|
Xiao J, Ng CH | PROSPERO
|
|
|
7/13/21
|
Kamara JK, Mahumud RA, Pingua NY, et al | PROSPERO
|
|
|
7/13/21
|
Coelho JG, da Silva Zamith HP, Guedes Borges HCB, et al | PROSPERO
|
|
|
7/13/21
|
Chen CY, Chen WC, Lai CC, et al | PROSPERO
|
|
|
7/13/21
|
Susanty S, Sarasmita MA, Chuang YH | PROSPERO
|
|
|
7/13/21
|
Sun Y, Chi HJ, Lee CY, et al | PROSPERO
|
|
|
7/13/21
|
Srisurapanont K, Kuentak V, Ketpueak T | PROSPERO
|
|
|
7/13/21
|
Neuhaus A, Buchan A, De Luca G, et al | PROSPERO
|
|
|
7/13/21
|
Gaikwad P, Nakade M, Kamble S, et al | PROSPERO
|
|
|
7/13/21
|
Batteux E, Mills F, Jones L, et al | PROSPERO
|
|
|
7/13/21
|
Mamo AG, Eshete MT | PROSPERO
|
|
|
7/13/21
|
Rosero ID, Lugo JLB, Cardona CMB | PROSPERO
|
|
|
7/13/21
|
Galanis P, Vraka I, Siskou O, et al | PROSPERO
|
|
|
7/13/21
|
Samuelkamaleshkumar S, Jeromedanypraveenraj J, Anand V, et al | PROSPERO
|
|
|
7/13/21
|
Budtarad N, Teerawattananon Y, Anothaisintawee T, et al | PROSPERO
|
|
|
7/13/21
|
Sung KY, Wang YP | PROSPERO
|
|
|
7/13/21
|
Kulkarni D, Nundy M, Hartnup K, et al | PROSPERO
|
|
|
7/12/21
|
Cavalini H, Delanerolle G, Neves V, et al | PROSPERO
|
|
|
7/12/21
|
Sutton A, Cantrell A, Simpson E, et al | PROSPERO
|
|
|
7/12/21
|
Sutton A, Cantrell A, Simpson E, et al | PROSPERO
|
|
|
7/12/21
|
Salaudeen MA, Magaji MG | PROSPERO
|
|
|
7/12/21
|
Salaudeen MA, Magaji MG, Abdullahi U | PROSPERO
|
|
|
7/12/21
|
Kuan PX, Law KB, Pathmananthan MD, et al | PROSPERO
|
|
|
7/12/21
|
Tian X, Gan W, Nie Y, et al. | BMJ Open
|
|
|
7/12/21
|
Cho E | PROSPERO
|
|
|
7/12/21
|
Beyene T, Geleto A | PROSPERO
|
|
|
7/12/21
|
Adrianto N, Caesarlia J, Pajala FB, | PROSPERO
|
|
|
7/12/21
|
Guan Z, Chen C, Li L, Yang S, et al | PROSPERO
|
|
|
7/12/21
|
Domingues KZA, Pontarolo R, Tonin FS, et al | PROSPERO
|
|
|
7/12/21
|
Ali MW, Farooq S, Ayub M | PROSPERO
|
|
|
7/12/21
|
Kassaw NA, Hassen HY | PROSPERO
|
|
|
7/12/21
|
Moayyedi P | McMaster University
|
|
|
7/12/21
|
Jiarui Z, Zhang G, Li S, et al | PROSPERO
|
|
|
7/9/21
|
Mutua V, Michael BH | PROSPERO
|
|
|
7/9/21
|
Dominic C, Hillyar C | PROSPERO
|
|
|
7/9/21
|
Panchal U, Salazar de Pablo G | PROSPERO
|
|
|
7/9/21
|
Hirt J, Janiaud P, Trounce M, et al | PROSPERO
|
|
|
7/9/21
|
Arora K, Awasthi V, Agarwal B, et al | PROSPERO
|
|
|
7/9/21
|
Wagner C, Griesel M, Fichtner F, et al | PROSPERO
|
|
|
7/9/21
|
Panchal U, Salazar de Pablo G | PROSPERO
|
|
|
7/9/21
|
Mandini S, Piva T, Zerbini V, et al | PROSPERO
|
|
|
7/9/21
|
Li M, Wang W, Gao W, et al | PROSPERO
|
|
|
7/9/21
|
Hu Y, Wang Y, Shao T | PROSPERO
|
|
|
7/9/21
|
Pranata R, Raffaelo W, Zein A | PROSPERO
|
|
|
7/9/21
|
Landoni G, Piemonti L, Zangrillo A, et al | PROSPERO
|
|
|
7/9/21
|
Deng J, Zhou F | PROSPERO
|
|
|
7/9/21
|
Deng J, Zhou F | PROSPERO
|
|
|
7/9/21
|
Das CK, Torfa AM, Alam F, et al | PROSPERO
|
|
|
7/9/21
|
Gomez IN, Suarez C, Tapang ML, et al | PROSPERO
|
|
|
7/8/21
|
Kuodi P, Edelstein M | PROSPERO
|
|
|
7/8/21
|
Pepera G, Tribali MS, Papathanassiou J | PROSPERO
|
|
|
7/8/21
|
Cisne FIM, Rodrigues ISA, de Andrade NJM, et al | PROSPERO
|
|
|
7/8/21
|
Amsalu E, Yeshambaw M, Biru M | PROSPERO
|
|
|
7/8/21
|
He F, Wei J, Gao B, et al | PROSPERO
|
|
|
7/7/21
|
John-Baptiste A, Moulin MS, Ali S, et al. | BMJ Open
|
|
|
7/7/21
|
Kuriyama A, Urakami Y, Sun R | PROSPERO
|
|
|
7/7/21
|
Yang Z, Wang X, Wan X, et al | PROSPERO
|
|
|
7/7/21
|
Prevalence of mechanical circulatory support in COVID-19 patients: a systematic review of literature
Mariani S, Lorusso R, Ravaux JM, et al | PROSPERO
|
|
|
7/7/21
|
Oh S, Kim EY | PROSPERO
|
|
|
7/7/21
|
Harwood R, Tan H, Da Camara NT, et al. | Research Square
Aim: To describe pre-existing factors associated with severe disease, primarily admission to critical care, and death secondary to SARS-CoV-2 infection in children and young people (CYP) in hospital.
|
|
|
7/6/21
|
Adhikari K, Deo G, Ghimire A, et al | PROSPERO
|
|
|
7/6/21
|
Arora K, Srivastava G, Singh L, et al | PROSPERO
|
|
|
7/6/21
|
Dal Santo T, Sun Y, Wu Y, et al. | medRxiv
Aim: To compare mental health symptom changes since pre-COVID-19 by sex or gender.
|
|
|
7/6/21
|
Larkin A, Waitzkin H | medRxiv
Aim: To clarify efficacy, effectiveness, and harm of available vaccines for COVID-19, using measures in evidence-based medicine (EBM) that, in addition to relative risk reduction, consider absolute risk reduction and variations in baseline risks.
|
|
|
7/6/21
|
Prado-Calleros H, Jimenez-Gutierrez C, Gutierrez-Castrellon P | PROSPERO
|
|
|
7/6/21
|
Jia R, Yu J, Liang D, et al. | Research Square
|
|
|
7/6/21
|
Low JM, Low YW | PROSPERO
|
|
|
7/6/21
|
Revathy R, Roy PK, Lavanta AC, et al | PROSPERO
|
|
|
7/6/21
|
Caputo E, Dumith S, Opelt L, Viero V | PROSPERO
|
|
|
7/6/21
|
Chao SC, Liao SC | PROSPERO
|
|
|
7/6/21
|
Ghanei M, Saadat SH, Najimi-Varzaneh A, et al. | Research Square
Aim: To estimate the overall prevalence in-hospital death due to COVID-19 disease in Iranian patients.
|
|
|
7/6/21
|
Phianhasin L, Benjasirisan C, Ruksakulpiwat S, et al | PROSPERO
|
|
|
7/6/21
|
Dalawi I, Isa MR, Wee CX, et al. | Research Square
|
|
|
7/6/21
|
Prata Menezes N, Malone J, et al. | Syst Rev
|
|
|
7/6/21
|
Padilla JGP, Paniagua WC, del Pilar Llaque Sanchez MR | PROSPERO
|
|
|
7/6/21
|
Oh S, Kim EY | PROSPERO
|
|
|
7/6/21
|
Härkänen M, Carrillo I, Tella S, et al | PROSPERO
|
|
|
7/6/21
|
Junwu W, Pengzhi S, Dong C, et al. | medRxiv
Aim: To analyze the safety and efficacy and investigate the potential value of MSCs therapy in patients with COVID-19 infection.
|
|
|
7/5/21
|
Amani A, Selenguai HK, Dairou IA, et al | PROSPERO
|
|
|
7/5/21
|
Sunuwar DR, Singh DR | PROSPERO
|
|
|
7/5/21
|
Xiao L, Liu M | PROSPERO
|
|
|
7/5/21
|
Roberto MAP, Gonzalez-Alvarez MA | PROSPERO
|
|
|
7/5/21
|
Mulyadi M, Tonapa SI, Lee BO | PROSPERO
|
|
|
7/5/21
|
Chen SY, Wu VC | PROSPERO
|
|
|
7/5/21
|
da Silva KM, Maggi LE, Moura SSO | PROSPERO
|
|
|
7/5/21
|
Malone A, O'Shea O, Kestell E | PROSPERO
|
|
|
7/5/21
|
Pinho-Gomes AC, Vasallo A, Thompson K, et al | PROSPERO
|
|
|
7/5/21
|
Rauniyar R, Rauniyar R, Rauniyar R, et al | PROSPERO
|
|
|
7/5/21
|
The collateral effect of COVID-19 on cardiovascular services: a systematic review with meta-analysis
Nadarajah R, Hurdus B, Wu J, et al | PROSPERO
|
|
|
7/5/21
|
Ito Y, Honda A | PROSPERO
|
|
|
7/5/21
|
Battaglini D, Robba C, Cho SM, et al | PROSPERO
|
|
|
7/5/21
|
Trott M, Olanrewaju O, Lindsay R, et al | PROSPERO
|
|
|
7/5/21
|
Tan A, Vogel J, Homer C, Bucknall T, et al | PROSPERO
|
|
|
7/2/21
|
Ab Rahman AS, Seidler AL | PROSPERO
|
|
|
7/2/21
|
Ab Rahman AS, Seidler AL | PROSPERO
|
|
|
7/2/21
|
Bellinato F, Gisondi P | PROSPERO
|
|
|
7/2/21
|
Bellinato F, Gisondi P | PROSPERO
|
|
|
7/2/21
|
Amini M, Doustmohammadian A | PROSPERO
|
|
|
7/2/21
|
Amini M, Doustmohammadian A | PROSPERO
|
|
|
7/2/21
|
Gong I, Cheung M | PROSPERO
|
|
|
7/2/21
|
Gong I, Cheung M | PROSPERO
|
|
|
7/2/21
|
Nelson S, Rostron J | PROSPERO
|
|
|
7/2/21
|
Nelson S, Rostron J | PROSPERO
|
|
|
7/2/21
|
Jin Y, Ren X, Zhang R, et al | PROSPERO
|
|
|
7/2/21
|
Jin Y, Ren X, Zhang R, et al | PROSPERO
|
|
|
7/2/21
|
Schmid B, Grummich K, Romero CS, et al | PROSPERO
|
|
|
7/2/21
|
Schmid B, Grummich K, Romero CS, et al | PROSPERO
|
|
|
7/2/21
|
Ji X, Zhi H, Chen R | PROSPERO
|
|
|
7/2/21
|
Ji X, Zhi H, Chen R | PROSPERO
|
|
|
7/2/21
|
Cooper J, Wort G, Lambert J, et al | PROSPERO
|
|
|
7/2/21
|
Cooper J, Wort G, Lambert J, et al | PROSPERO
|
|
|
7/2/21
|
de Oliveira Brügger LM, Araujo ST, e Castro RS, et al | PROSPERO
|
|
|
7/1/21
|
Chen X, Li H, Zheng X, et al. | Medicine
|
|
|
7/1/21
|
da Silva Toscano GA, de Araújo II, de Souza TA, et al. | Medicine
|
|
|
6/30/21
|
Mitton C | University of British Columbia
|
|
|
6/29/21
|
Pacheco JA, Molena KF, Martins CROG CROG, et al. | Research Square
Aim: To review the evidence on whether photobiomodulation (PBM) and antimicrobial photodynamic therapy (aPDT) effective to treat oral manifestations of patients infected with SARS-CoV-2. UPDATED
|
|
|
6/29/21
|
Hosen I, al Mamun F, Mamun MA | Research Square
Aim: To review the Bangladeshi literature related to common mental health problems (i.e., depression, anxiety and stress) conducted during the COVID-19 pandemic.
|
|
|
6/29/21
|
Junhai Z, Jing Y, Shijin G, et al. | Research Square
Aim: To systematically investigate the predictive capacity of ROX index for HFNC failure.
|
|
|
6/28/21
|
Emilian CA, Daalen KV, Persad E, et al | PROSPERO
|
|
|
6/28/21
|
Aggarwal N, Fessel J, Williams J, et al | PROSPERO
|
|
|
6/28/21
|
Sanchez SO, Monzó AP, Rieger ED | PROSPERO
|
|
|
6/28/21
|
Ruiz G, Jiménez FL | PROSPERO
|
|
|
6/28/21
|
Chen S, Lodge C, Dharmage S | PROSPERO
|
|
|
6/28/21
|
Mekonnen BD, Mengistu BA, et al | PROSPERO
|
|
|
6/28/21
|
Sheikh NA, Tripathi R, Vasudeva A | PROSPERO
|
|
|
6/28/21
|
Farooqui K, Sardar S, Habib MB, et al | PROSPERO
|
|
|
6/28/21
|
Kumar S, Narasimha GVL | PROSPERO
|
|
|
6/28/21
|
Fernandes M, Nacif LS | PROSPERO
|
|
|
6/28/21
|
Chaudhary S, Panda S, Anjum S, et al | PROSPERO
|
|
|
6/28/21
|
Amorim dos Santos J, Di Carvalho Melo L, costa Normando AG, et al | PROSPERO
|
|
|
6/28/21
|
Gok S, Gillissie ES, Lui LMW, et al | PROSPERO
|
|
|
6/28/21
|
Flanagan J, Soumbasis A, Dimitropoulos G, et al | PROSPERO
|
|
|
6/28/21
|
Charakopoulou-Travlou M, Ntakolia C, Rannou I, et al | PROSPERO
|
|
|
6/28/21
|
Maxwell JL, Brennan UE | PROSPERO
|
|
|
6/25/21
|
Gao Y, Ma L, Su J | PROSPERO
|
|
|
6/25/21
|
Carrera KS, Iturrizaga IM | PROSPERO
|
|
|
6/25/21
|
Silva W, Oliveira A, Brito S, et al | PROSPERO
|
|
|
6/25/21
|
Shah S, Chamlagain R | PROSPERO
|
|
|
6/25/21
|
Mohammadi M, Vepa A, Khunti K, et al | PROSPERO
|
|
|
6/25/21
|
Reid A, Highfield F, Verma A | PROSPERO
|
|
|
6/25/21
|
Raya R, Oyelade T, Kamila A | PROSPERO
|
|
|
6/25/21
|
D'Angelo F, Marceca M, Tosti ME , et al | PROSPERO
|
|
|
6/25/21
|
Adhikari A, Pokharel S, Dittrich S | PROSPERO
|
|
|
6/25/21
|
Liang D, Jia R, Yu J, et al | PROSPERO
|
|
|
6/25/21
|
Yu P, Khalid F, Li A, et al | PROSPERO
|
|
|
6/23/21
|
Mekonnen M, Abebaw D, Berhanu M, et al | PROSPERO
|
|
|
6/23/21
|
Abbasian S, Shokrgozar N, Abbasian H | PROSPERO
|
|
|
6/23/21
|
de Andrade Rezende I, Lopes Almeida MI, et al | PROSPERO
|
|
|
6/23/21
|
Nagarajan VR, Alshamlan A, Adulhadi A, et al | PROSPERO
|
|
|
6/23/21
|
Cuevas-Gonzalez JC, Cuevas-Gonzalez MV | PROSPERO
|
|
|
6/23/21
|
Thu AK, Aung TH | PROSPERO
|
|
|
6/23/21
|
Learmonth YC, Marck C, Mathersul D, et al | PROSPERO
|
|
|
6/23/21
|
Verma P, Kerrison R | PROSPERO
|
|
|
6/23/21
|
Subasinghe K, Pathiranage AMSD | PROSPERO
|
|
|
6/23/21
|
Budi DS, Pratama NR, Wafa IA, et al | PROSPERO
|
|
|
6/23/21
|
Nandasena HMRKG, Prasanga PTS | PROSPERO
|
|
|
6/23/21
|
Alberto R, Azevedo FM, Silva DLF, et al | PROSPERO
|
|
|
6/23/21
|
Gerson EM, Kotlar B, Cohen R, et al | PROSPERO
|
|
|
6/23/21
|
Posso M, Parra L, Ortegon V, et al | PROSPERO
|
|
|
6/22/21
|
Malinga DM, Abdullah L, Adam A, et al | PROSPERO
|
|
|
6/22/21
|
Colombo T, Stein A, Cazella S, et al | PROSPERO
|
|
|
6/22/21
|
Ahillan T, Emmerson M, Golamgouse H, et al | PROSPERO
|
|
|
6/22/21
|
ZoghAli M, Rayegani SM, Aalipour K, et al | PROSPERO
|
|
|
6/22/21
|
Trushna T, Diwan V, Madhanraj K, et al | PROSPERO
|
|
|
6/22/21
|
Shrestha A, Adhikari N, Shrestha AP, et al | PROSPERO
|
|
|
6/22/21
|
Boltena MT, El-Khatib Z, Biru M | PROSPERO
|
|
|
6/22/21
|
Love C, Leimanis M, Rajasekaran S, et al | PROSPERO
|
|
|
6/22/21
|
Neuropsychological deficits in patients with persistent COVID: A systematic review and meta-analysis
Sobrino-Relaño S, Balboa-Bandeira Y, Peña J, et al | PROSPERO
|
|
|
6/22/21
|
Liu J, Yang Y | PROSPERO
|
|
|
6/22/21
|
Ortiz E, Castillo AAA, Sevillano OEP, Pizarro YP, et al | PROSPERO
|
|
|
6/22/21
|
Silveira E, Romeiro A, Junger AL, et al | PROSPERO
|
|
|
6/22/21
|
Boltena MT, El-Khatib Z, Biru M | PROSPERO
|
|
|
6/22/21
|
Correia R, Nogueira J, Coelho J, et al | PROSPERO
|
|
|
6/22/21
|
Trezena S, Soares de Oliveira FE, Júnior HM | PROSPERO
|
|
|
6/22/21
|
Larran J, Hein S | PROSPERO
|
|
|
6/22/21
|
Spencer N, Markham W, Johnson S, et al | PROSPERO
|
|
|
6/22/21
|
Urhi A, Feyikemi F, Olatunde H, et al | PROSPERO
|
|
|
6/22/21
|
Gleeson L, Flood M, Moriarty F | PROSPERO
|
|
|
6/22/21
|
Khanna P, Chattu V | PROSPERO
|
|
|
6/21/21
|
Budhathoki P, Shrestha D, Pokharel N, et al | PROSPERO
|
|
|
6/21/21
|
Gutierrez-Zevallos JD, Espiritu-Martinez LB, Melendez-Benites CR, et al | PROSPERO
|
|
|
6/21/21
|
Villarreal-Garza C, Becerril-Gaitan A, Vaca-Caragena B, et al | PROSPERO
|
|
|
6/21/21
|
Chen W, Yin C, Zhong M, et al. | Research Square
Aim: To identify studies systematically that describe the incidence and risks factors of CAPA, and to assess its outcome.
CLINICAL CHARACTERISTICS
|
|
|
6/21/21
|
Seaborn K, Chignell M, Gwizdka J | BMJ Open
|
|
|
6/17/21
|
Moraes VY, Marra AR, Matos LL, et al. | Research Square
Aim: To review the evidence on the efficacy and safety of hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) patients. UPDATED
|
|
|
6/16/21
|
Debela DT, Heraro KD, Fekadu A, et al. | Research Square
|
|
|
6/16/21
|
Rong J, Li J, Jing F, et al. | Medicine
|
|
|
6/16/21
|
Sun P, Yan D, Li B, et al. | Medicine
CANDIDATE THERAPEUTICS
|
|
|
6/15/21
|
Wafa IA, Pratama NR, Sofia NF, et al. | Preprints.org
Aim: To investigate the differences in metabolic control parameters in diabetic patients before and during the lockdown. UPDATED
|
|
|
6/14/21
|
Zhu J, Long Q, Mao H, et al. | Medicine
CANDIDATE THERAPEUTICS
|
|
|
6/11/21
|
Qureshi B, Albury C, Osahon DP, et al | PROSPERO
|
|
|
6/11/21
|
Hariyanto TI, Intan D, Kurniawan A | PROSPERO
|
|
|
6/11/21
|
Schmidbauer ML, Ferse C, Salih F, et al. | Research Square
Aim: To systematically investigate incidence, mortality, radiological subtypes and clinical characteristics of ICH in COVID-19 patients.
|
|
|
6/11/21
|
López-Soto PJ, Morales-Cané I, de la Cruz López-Carrasco | PROSPERO
|
|
|
6/11/21
|
Huang L, Wang L, Tan J, et al. | Medicine
|
|
|
6/11/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
6/11/21
|
Wang H, Jiang H, Zhao J, et al. | Medicine
|
|
|
6/11/21
|
Hooper L, Clark R, Pearce-Smith S | PROSPERO
|
|
|
6/10/21
|
Octavius GS, Chandra S, Wijaya JH, et al. | Research Square
Aim: To describe the clinical manifestations and laboratory findings of pediatric patients with neurological manifestations of COVID-19. UPDATED
|
|
|
6/10/21
|
Mohebbi SZ, Ebrahimi T, Shamshiri AR | Preprints.org
Aim: To investigate the effects of mouthwashes on covid-19 viral load reduction during dental practices and oro-pharyngeal assessments.
|
|
|
6/10/21
|
Prakash O, Jha A, Kumar A, et al | PROSPERO
|
|
|
6/10/21
|
Sah SK, Shariff A, Niharika P, et al | PROSPERO
|
|
|
6/10/21
|
Habibzadeh A, Tabrizi R, Farjam M, et al | PROSPERO
|
|
|
6/10/21
|
Whear R, Rogers M, Bethel A, et al | PROSPERO
|
|
|
6/9/21
|
Hülsemann M, Drude NI, Kniffert S, et al | PROSPERO
|
|
|
6/9/21
|
Franchini M, Cruciani M | PROSPERO
|
|
|
6/9/21
|
Alamolhoda SH, Zare E, Mirabi P | PROSPERO
|
|
|
6/9/21
|
Trushna T, Madhanraj K, Dhiman V, et al | PROSPERO
|
|
|
6/9/21
|
Dedeilia A, Papadopoulos A, Papapanou M, et al | PROSPERO
|
|
|
6/9/21
|
Sreeka A, Rohini AM | PROSPERO
|
|
|
6/9/21
|
Tasew H, Teklay G, Bahrey D | PROSPERO
|
|
|
6/9/21
|
Lopez-Padilla D, Gonzalez VG, Castillejo EO, et al | PROSPERO
|
|
|
6/9/21
|
Tasew H, Bahrey D, Teklay G | PROSPERO
|
|
|
6/9/21
|
Meng L, Zhou Y, Wu L, et al | PROSPERO
|
|
|
6/9/21
|
Su H, Ma K | PROSPERO
|
|
|
6/9/21
|
Rowland-Pomp M, Hargreaves S, Goldsmith LP, et al | PROSPERO
|
|
|
6/9/21
|
Kumar A, Datusalia AK | PROSPERO
|
|
|
6/8/21
|
Karimi-Shahanjarin A, Afshari M, Miri A, et al | PROSPERO
|
|
|
6/8/21
|
Lim M, Yeo J, Fong KY, et al | PROSPERO
|
|
|
6/8/21
|
Menezes R, Martimbiano AL, Fragoso Y | PROSPERO
|
|
|
6/8/21
|
Pandey S, Devkota A, Raut U, et al | PROSPERO
|
|
|
6/8/21
|
Mohanty R, Padhy BM, Meher BR | PROSPERO
|
|
|
6/8/21
|
Zhang KX, Zhou Y, Dong ZB | PROSPERO
|
|
|
6/8/21
|
Teoh SE, Masuda Y, Tan DJH, et al | PROSPERO
|
|
|
6/8/21
|
Tiwari S, Isnuwardana R, KC N, et al | PROSPERO
|
|
|
6/8/21
|
Auroux M, Lega JC, Cabrera N, et al | PROSPERO
|
|
|
6/8/21
|
Chen KX, Yin LW | PROSPERO
|
|
|
6/8/21
|
Wang X, Connelly J, Huang Y | PROSPERO
|
|
|
6/8/21
|
He Y, Bai X, Zhu T, et al | PROSPERO
|
|
|
6/7/21
|
Chowdhury F, Lynch M, Spencer LH | PROSPERO
|
|
|
6/7/21
|
Dhakal S, Poovorawan K, Hanboonkunupakarn B | PROSPERO
|
|
|
6/7/21
|
Genis H, Wong E, Tse T, et al | PROSPERO
|
|
|
6/7/21
|
Gutierrez-Zevallos JD, Espiritu-Martinez LB, Loyaga-Flores AM, et al | PROSPERO
|
|
|
6/7/21
|
Meng X, Liu M, Su Y | PROSPERO
|
|
|
6/7/21
|
McIntosh L, O'Neill G, Lee X | PROSPERO
|
|
|
6/7/21
|
Christoforidis A, Dimitriadou M, Triantafyllou P | PROSPERO
|
|
|
6/7/21
|
Budiman J, Kurnianto A | PROSPERO
|
|
|
6/6/21
|
Domingo FR, Waddell LA, Cheung AM, et al. | medRxiv
Aim: To document the prevalence of post COVID-19 conditions 4-12 weeks (short-term) and >12 weeks (long-term) after COVID-19 diagnosis. UPDATED
|
|
|
6/4/21
|
Kelly S | CRMC at University of Ottawa Heart Institute
|
|
|
6/4/21
|
Sgandurra G, Bombonato C, Del Lucchese B, et al | PROSPERO
|
|
|
6/4/21
|
Batra K, Pharr J, Godbey S, et al | PROSPERO
|
|
|
6/4/21
|
Karmarkar J, Budhraja N, Ingole P, et al | PROSPERO
|
|
|
6/4/21
|
Hohlfeld A, Engel ME | PROSPERO
|
|
|
6/4/21
|
Kelly S | CRMC at University of Ottawa Heart Institute
|
|
|
6/4/21
|
Hawco S, Rolnik D, Mol B, et al | PROSPERO
|
|
|
6/4/21
|
Xiaoli Y, Yin H, Peng L | PROSPERO
|
|
|
6/4/21
|
Su E, Parmasar S, McIntyre R, et al | PROSPERO
|
|
|
6/4/21
|
Lee EY, Lim H, Lee M, et al | PROSPERO
|
|
|
6/4/21
|
Wang Q, Shasha G | PROSPERO
|
|
|
6/4/21
|
Castelletti C, Lara E, Dolz del Castellar B, et al | PROSPERO
|
|
|
6/4/21
|
Garrido-Ardila EM, Rodriguez-Mansilla J, Bedmar-Vargas C, et al | PROSPERO
|
|
|
6/3/21
|
Kite C, Lagojda L, Clark CCT, et al. | Int J Environ Res Public Health
|
|
|
6/3/21
|
Pandey SR, Shrestha S, Bhandari S, et al | PROSPERO
|
|
|
6/3/21
|
De Azevedo T, Pereira CF, De Paula Gonçalves VG, et al | PROSPERO
|
|
|
6/3/21
|
Chan CS, Kong JY, Babata KL, et al. | Cochrane Database Syst Rev
|
|
|
6/3/21
|
D'Costa A, Olaussen A, Guzzo S | PROSPERO
|
|
|
6/3/21
|
Junxiong J, Pang V, Chua P, et al | PROSPERO
|
|
|
6/3/21
|
Fun W, Sivajohan B, Money D, et al | PROSPERO
|
|
|
6/3/21
|
Sun Y, Sun R, Liu J, et al | PROSPERO
|
|
|
6/2/21
|
Chandran V, Rashid M, Thunga G, et al | PROSPERO
|
|
|
6/2/21
|
Meena JP, Gupta A, Haldar P | PROSPERO
|
|
|
6/2/21
|
Tandaju J, Mangkuliguna G | PROSPERO
|
|
|
6/2/21
|
Hoang NA, Vogt F, Quach HL | PROSPERO
|
|
|
6/2/21
|
Limen RY, Sedono R, Sugiarto A, et al | PROSPERO
|
|
|
6/2/21
|
Lim ZJ, Subramaniam A, Shekar K | PROSPERO
|
|
|
6/2/21
|
Marcolino M, Mota P, Bruschi Kelles SM, Sá LC, et al | PROSPERO
|
|
|
6/1/21
|
Mangoni A, Zinellu A | PROSPERO
|
|
|
6/1/21
|
Kharel S, Thapaliya D, Pokharel S, et al | PROSPERO
|
|
|
6/1/21
|
Hossain MS, Hussain F, Amin MT, et al | PROSPERO
|
|
|
6/1/21
|
Liu Z, Zeng Y, Yang B | PROSPERO
|
|
|
6/1/21
|
Guo Y, Zheng YJ, Yu B | PROSPERO
|
|
|
6/1/21
|
Irfan O, Tang K | PROSPERO
|
|
|
6/1/21
|
Wu T, Jia X, Xu H, et al | PROSPERO
|
|
|
6/1/21
|
MH Møller, Perner A | PROSPERO
|
|
|
6/1/21
|
Mittal S, Boppana TK, Madan K, et al | PROSPERO
|
|
|
6/1/21
|
Weber M, Brauns I, Kluge JK, et al | PROSPERO
|
|
|
6/1/21
|
Danwang C, Noubiap JJ, Robert A, et al | PROSPERO
|
|
|
6/1/21
|
De Lucca Da Silva J, de Araújo BC, Luquine Júnior CD, et al | PROSPERO
|
|
|
6/1/21
|
Sharma P, Wadhwan V, Malik S, et al | PROSPERO
|
|
|
6/1/21
|
Interior J, Garcia J, Sulpicio III Yu G, Ligsay A, et al | PROSPERO
|
|
|
6/1/21
|
Gates M, Pillay J, Wingert A, et al. | medRxiv
Aim: To inform vaccine prioritization guidance by the National Advisory Committee on Immunization (NACI). UPDATED
|
|
|
6/1/21
|
Zong K, Peng D, Luo Y, et al | PROSPERO
|
|
|
6/1/21
|
Luquine Jr. CD, Milhomens LM, Domene FM, et al | PROSPERO
|
|
|
6/1/21
|
Kirubarajan A, Park B, Abi-Jaoude E | PROSPERO
|
|
|
6/1/21
|
Ye F, Wang T, Wang X, et al | PROSPERO
|
|
|
6/1/21
|
Ngamprasertchai T, Kajeekul R, Luangasanatip N | PROSPERO
|
|
|
6/1/21
|
Jones-Williams E, Nykjaer C | PROSPERO
|
|
|
6/1/21
|
Rocha YM, Acácio de Moura G, Desidério GA | PROSPERO
|
|
|
6/1/21
|
Ortega-Paz L, Galli M | PROSPERO
|
|
|
6/1/21
|
Favas TT, Kumar A, Pathak A, et al | PROSPERO
|
|
|
5/28/21
|
Suh S, Lee S, Gym H, et al. | Research Square
Aim: To discover the related SNPs of SARS-CoV-2 infection.
|
|
|
5/28/21
|
Stegemann M, Mikolajewska A, Benstoem C, et al | PROSPERO
|
|
|
5/28/21
|
Smith C, Gilbert E, Lomisar J, et al | PROSPERO
|
|
|
5/28/21
|
Sajjan P, Kulkarni V | PROSPERO
|
|
|
5/28/21
|
Maraolo AE, Attena E, Nerilli M, et al | PROSPERO
|
|
|
5/28/21
|
Campbell J, Hobbs M, O'Hara L, et al. | BMJ Open
|
|
|
5/28/21
|
Ruberti E, Flla E | PROSPERO
|
|
|
5/28/21
|
Song H, Chia A, Tan B, et al | PROSPERO
|
|
|
5/28/21
|
Morin A, Sideris M, Palamarchuk T, et al | PROSPERO
|
|
|
5/27/21
|
Anticoagulation and Covid 19 outcome of hospitalized patients; a systematic review and meta-analysis
Waheed M, Rashid K, Fayyaz H, et al | PROSPERO
|
|
|
5/27/21
|
Jiao B, Chen M | PROSPERO
|
|
|
5/27/21
|
Ceban F, Ling S, Lui L, et al | PROSPERO
|
|
|
5/27/21
|
Kakodkar PV, Jagtap P, Kale S, et al | PROSPERO
|
|
|
5/27/21
|
Provost E, Thellier D, Auditeau E | PROSPERO
|
|
|
5/27/21
|
Su X, Lu H, Li X, et al | PROSPERO
|
|
|
5/27/21
|
Ab Rahman AS, Saffian SM, Al-Busaidi IS | PROSPERO
|
|
|
5/27/21
|
Du P, Chen W, Luo X, et al. | Research Square
Aim: To compare the time intervals from onset to first medical visit and onset to the hospitalization of COVID-19 patients in different regions and assess the supply and demand status of medical resources.
|
|
|
5/27/21
|
Costa C, Nogueira MN, Araújo J | PROSPERO
|
|
|
5/27/21
|
Liang D, Jia R, Yu J, et al | PROSPERO
|
|
|
5/27/21
|
Cavalcante T, Jansen R | PROSPERO
|
|
|
5/27/21
|
Vieira GN, Remualdo RJ, Lubsinski T, et al | PROSPERO
|
|
|
5/27/21
|
Gubert V, do Valle Leone de Oliveira SM, Cavalcante TM, et al | PROSPERO
|
|
|
5/27/21
|
Abate S, Nega S, Mantefardo B | PROSPERO
|
|
|
5/27/21
|
Pereira M, Mamelund SE, Dimka J, et al | PROSPERO
|
|
|
5/27/21
|
Low CJW, Tham GY, Ling R, et al | PROSPERO
|
|
|
5/27/21
|
Sanchez-Ramirez DC, Torres Castro R | PROSPERO
|
|
|
5/27/21
|
Jannuzi M, Turcio K, Júnior JS, et al | PROSPERO
|
|
|
5/27/21
|
Winata IGS, Simatupang J, Polim AA, et al | PROSPERO
|
|
|
5/27/21
|
Moron-Duarte LS, Yomayusa N, Low E | PROSPERO
|
|
|
5/27/21
|
Savitri NH, Sakinah BI, Setyawan C, et al | PROSPERO
|
|
|
5/27/21
|
Cavalcante T, Meiru C | PROSPERO
|
|
|
5/27/21
|
Ogunsiji O, Avila T, Kaur A, et al | PROSPERO
|
|
|
5/27/21
|
Peng S, Xie Z, Zhang X, et al. | Research Square
|
|
|
5/27/21
|
Jerjes-Sánchez C, Castro-Varela A, Solorzano-Lopez EJ, et al | PROSPERO
|
|
|
5/26/21
|
Sadjadi R | Preprints.org
Aim: To evaluate the prevalence of depression, anxiety, insomnia, stress, PTSD, and distress in Chinese healthcare workers (HCWs) and the changes in prevalence before and after the peak incidence of COVID-19 in China.
|
|
|
5/26/21
|
Hooper L, Sadler L, Clark R, et al | PROSPERO
|
|
|
5/26/21
|
Negrini F, Negrini S, Ceravolo MG, et al | PROSPERO
|
|
|
5/25/21
|
Dhiman N, Joshi D | PROSPERO
|
|
|
5/25/21
|
Reissner S, Sönnichsen A | PROSPERO
|
|
|
5/25/21
|
Piechotta V, Andreas M, Fischer AL, et al | PROSPERO
|
|
|
5/25/21
|
Nunes ML, Pai JD, Richter SA, et al | PROSPERO
|
|
|
5/25/21
|
de Chickera S, Wang C, Sandal S, et al | PROSPERO
|
|
|
5/25/21
|
Li Q, Wang S, He YH, et al | PROSPERO
|
|
|
5/25/21
|
Nunes ML, Pai JD, Tieppo C, et al | PROSPERO
|
|
|
5/25/21
|
Mohammadi M, Salari N, Hosseinian-Far A, et al | PROSPERO
|
|
|
5/25/21
|
Haas J, Bender F, Ballou S, et al | PROSPERO
|
|
|
5/25/21
|
Khanal P, Hanley D | PROSPERO
|
|
|
5/25/21
|
Nagarajan R, Krishnamoorthy Y, Jayashankar P | PROSPERO
|
|
|
5/25/21
|
Gupta P, Sarkar P, Kumar A | PROSPERO
|
|
|
5/25/21
|
Capic T, Mansour K, Misuraca G, et al | PROSPERO
|
|
|
5/25/21
|
Dehesh P, Torkiyan S | PROSPERO
|
|
|
5/25/21
|
Uzzi C, Oladunjoye F, Urhi A, et al | PROSPERO
|
|
|
5/25/21
|
Chen D, Hou X | PROSPERO
|
|
|
5/25/21
|
Brakspear L, Boules D, Burmester V, et al | PROSPERO
|
|
|
5/24/21
|
Konnyu K, Crawshaw J, Castillo G, et al. | PROSPERO
|
|
|
5/24/21
|
Limongi F, Siviero P, Noale M, et al. | PROSPERO
|
|
|
5/24/21
|
Dal Pai J, Nunes ML, Richter SA, et al. | PROSPERO
|
|
|
5/24/21
|
Rashid M, Rajan AK, Patel D, et al. | PROSPERO
|
|
|
5/24/21
|
George T J, Verma R, Shafqat N | PROSPERO
|
|
|
5/24/21
|
Refaat M, Iskandarani G, Ghazzal B, et al. | PROSPERO
|
|
|
5/24/21
|
de Carvalho Lavor LC, do Nascimento Monteiro NV, de Macêdo Gonçalves Frota K, et al. | PROSPERO
|
|
|
5/24/21
|
JingWen X, Zhang JJ, Zhang H, et al. | PROSPERO
|
|
|
5/24/21
|
Barman A, Sinha M, Sahoo J, et al. | PROSPERO
|
|
|
5/24/21
|
Epidemiology of psychiatric emergencies in the context of the COVID-19 pandemic: a systematic review
Ventura TF, Pereira LA, Soares NG | PROSPERO
|
|
|
5/24/21
|
Ding S, Deng S, Zhang Y, et al. | PROSPERO
|
|
|
5/24/21
|
Abate S Mantefardi B, Nega S | PROSPERO
|
|
|
5/24/21
|
Zhou C, Tian L, Kang W, et al. | PROSPERO
|
|
|
5/23/21
|
Wheeler S, Overland M | PROSPERO
|
|
|
5/21/21
|
Cruciani M, Pati I, Masiello F, et al | PROSPERO
|
|
|
5/21/21
|
Zawislak RB, de Azevedo M, Dussin AZ, et al | PROSPERO
|
|
|
5/21/21
|
de Souza Cazarim M, Cruz-Cazarim ELC, Azevedo PS, et al | PROSPERO
|
|
|
5/21/21
|
Maru V, Bapat S | PROSPERO
|
|
|
5/21/21
|
Décary S | Universite de Sherbrooke
|
|
|
5/21/21
|
Deng WS, Yang SS, Chen JS | PROSPERO
|
|
|
5/21/21
|
Zhao J, Guo D, Fan M, et al. | Medicine
|
|
|
5/21/21
|
Kim E, Choi J, Min SY, et al. | Medicine
|
|
|
5/21/21
|
Jankowski M, McIntyre R | PROSPERO
|
|
|
5/21/21
|
Prasad A, Kumar A, Chauhan G, et al | PROSPERO
|
|
|
5/21/21
|
Ramirez I, Haddad M, Soares L, et al | PROSPERO
|
|
|
5/21/21
|
Haung R, Fan W, Xie L, et al | PROSPERO
|
|
|
5/21/21
|
Pandey M, Pathak A, Kumar T, et al | PROSPERO
|
|
|
5/20/21
|
Maleki M, Nasrabadi AN, Abbasi S | PROSPERO
|
|
|
5/20/21
|
Shi C, Wu M | PROSPERO
|
|
|
5/20/21
|
Paludan-Müller AS, Lundh A, Munkholm K, et al | PROSPERO
|
|
|
5/20/21
|
Mohanty R, Das S, Padhy BM, et al | PROSPERO
|
|
|
5/20/21
|
Sun YM, Sun R, Liu JY, Li GP, et al | PROSPERO
|
|
|
5/20/21
|
Deady M, Collins D, Mobbs S, et al | PROSPERO
|
|
|
5/20/21
|
Ponnam HB, Akondi BR, Elaprolu M, et al | PROSPERO
|
|
|
5/20/21
|
Ignatowicz A, Tarrant C, Lasseron D, et al | PROSPERO
|
|
|
5/20/21
|
Liang D, Jia R, Yu J, et al | PROSPERO
|
|
|
5/20/21
|
Hariyanto TI, Intan D, Hananto JE, et al | PROSPERO
|
|
|
5/19/21
|
Li X, Lai LYH | PROSPERO
|
|
|
5/19/21
|
Vakhshoori M, Heidarpour M, Bondariyan N, et al | PROSPERO
|
|
|
5/19/21
|
Prakash J, Kumar D, Shrivastava P, et al | PROSPERO
|
|
|
5/19/21
|
Dewa L, Demkowicz O, Scott S | PROSPERO
|
|
|
5/19/21
|
Tang PT, Wijesurendra R, Ginks M | PROSPERO
|
|
|
5/19/21
|
Cui Y, Sun Y, Sun J, et al. | Research Square
Aim: To synthesize evidence for the relationship between corticosteroid use and mortality in COVID-19 patients. UPDATED
|
|
|
5/19/21
|
Pasin L, Landoni G | PROSPERO
|
|
|
5/19/21
|
Bartake A, Aditya A, Narang B, et al | PROSPERO
|
|
|
5/19/21
|
Bakr A, El-Sakka A | PROSPERO
|
|
|
5/19/21
|
Sachan D, Kumar S, Jain P, et al | PROSPERO
|
|
|
5/19/21
|
Vakhshoori M, Shafie D, Heidarpour M, et al | PROSPERO
|
|
|
5/19/21
|
De Souza Dos Santos G, Meier MJ, Melo Mato EV, et al | PROSPERO
|
|
|
5/19/21
|
Boaitey KP, Bakhit M, Hoffmann T, et al | PROSPERO
|
|
|
5/19/21
|
Vishal V, Khaitan T | PROSPERO
|
|
|
5/19/21
|
Gunasekaran V, Natarajan H, Sekar D | PROSPERO
|
|
|
5/19/21
|
Marra A, Schweizer M, Suzuki H, et al | PROSPERO
|
|
|
5/19/21
|
The impact of home working on the health of working people and health inequalities in the population
Blank L, Hock E, Cantrell A, et al | PROSPERO
|
|
|
5/19/21
|
Gargiulo M, Abualhin MA, Campana F | PROSPERO
|
|
|
5/19/21
|
Moroni FT, de Souza Pereira L, Garcia PA | PROSPERO
|
|
|
5/19/21
|
Valeriani F, Margarucci LM | PROSPERO
|
|
|
5/19/21
|
Kukreti S, Ko NY, Lin CY, et al | PROSPERO
|
|
|
5/18/21
|
Kamal A, Pearce J, Hodson A | PROSPERO
|
|
|
5/18/21
|
Pathitathna ML, Samarasekara BPP, Dasanayake TS, et al | PROSPERO
|
|
|
5/18/21
|
Kirmizitoprak E, Ortabag T | PROSPERO
|
|
|
5/18/21
|
Wang H, Sun C, Guo X, et al | PROSPERO
|
|
|
5/18/21
|
Renaud-Charest O, McIntyre R | PROSPERO
|
|
|
5/18/21
|
Mazzitelli M, Cattelan A | PROSPERO
|
|
|
5/18/21
|
Tekantapeh ST, Soleimanpour H, Ghojazadeh M, et al | PROSPERO
|
|
|
5/18/21
|
Paul SS, Ray A, Meena VP, et al | PROSPERO
|
|
|
5/18/21
|
Lopes J, Silva J, Ferreira W, et al | PROSPERO
|
|
|
5/18/21
|
Jahan N, Brahma A, Soman B, et al | PROSPERO
|
|
|
5/18/21
|
Zhao Y, Zhou C, Yin H, et al | PROSPERO
|
|
|
5/18/21
|
Sahu A, Malhotra C, Ramaswami A, et al | PROSPERO
|
|
|
5/18/21
|
Kirubarajan A, Park B, Abi-Jaoude E | PROSPERO
|
|
|
5/17/21
|
Caxias de Souza JS, Caxias de Souza CS | PROSPERO
|
|
|
5/17/21
|
Sam AQ, Sudaryo MK | PROSPERO
|
|
|
5/17/21
|
Strurrock S, Ali S | PROSPERO
|
|
|
5/17/21
|
Roy D, Ghosh R, Dubey S, et al | PROSPERO
|
|
|
5/17/21
|
Alrashdi M, Purcell C | PROSPERO
|
|
|
5/17/21
|
Reis L, Mesquita E, Carraro A, et al | PROSPERO
|
|
|
5/14/21
|
Pegollo L, Maggioni E, Odone A, et al | PROSPERO
|
|
|
5/14/21
|
Hosseini B, Ducharme F | PROSPERO
|
|
|
5/14/21
|
Caminiti C, Maglietta G, Diodati F, et al | PROSPERO
|
|
|
5/14/21
|
Leggio L, Havelka EM, Sanfilippo j | PROSPERO
|
|
|
5/13/21
|
Mazza C, Girardi D, Odone A, et al | PROSPERO
|
|
|
5/13/21
|
Choi S, Pokharel A, Cherng Ong KI, et al | PROSPERO
|
|
|
5/13/21
|
Qi X, Wang Y, Guangyu A | PROSPERO
|
|
|
5/13/21
|
Oyibo K, Sahu KS, Oetomo A, et al. | JMIR Res Protoc
|
|
|
5/13/21
|
Alberti FF, Gossenheimer AN | PROSPERO
|
|
|
5/13/21
|
Sert H, Trabzon S, Ilhan P | PROSPERO
|
|
|
5/13/21
|
Jagoda T, Rathnayake S | PROSPERO
|
|
|
5/13/21
|
Vajda M, Szakó L, Hegyu P, Schandl K | PROSPERO
|
|
|
5/13/21
|
Khoda TF, Abargoeui AS, Sadeghi M, et al | PROSPERO
|
|
|
5/13/21
|
Yeo G, Remus A, Leong QY, et al | PROSPERO
|
|
|
5/13/21
|
Hessami K, Shamshirsaz A | PROSPERO
|
|
|
5/12/21
|
Verma SK, Mohan S, Singh N, et al | PROSPERO
|
|
|
5/12/21
|
Whitehall J, Cook E, | PROSPERO
|
|
|
5/12/21
|
Saragih ID, Batubara SO | PROSPERO
|
|
|
5/12/21
|
Kim MS, Park S | PROSPERO
|
|
|
5/12/21
|
Magalhães F, Lopes G, Silva M, et al | PROSPERO
|
|
|
5/12/21
|
Zhu H, Yang X, Xie S, et al | PROSPERO
|
|
|
5/12/21
|
Tong J, Liu W | PROSPERO
|
|
|
5/12/21
|
Azam M, Bahrudin U, Ratnawati M, et al | PROSPERO
|
|
|
5/12/21
|
Tarhan G, Orsal O, Duru P | PROSPERO
|
|
|
5/12/21
|
Lu L, Shu-wen Y, Jung X | PROSPERO
|
|
|
5/12/21
|
Idzerda L, Gariepy G, Belcourt V, et al | PROSPERO
|
|
|
5/12/21
|
Patel K, Guo K, McGregor S, et al | PROSPERO
|
|
|
5/11/21
|
Adepu SK, Beyer F, Insan N, et al | PROSPERO
|
|
|
5/11/21
|
Sarkar PG, Kumar A | PROSPERO
|
|
|
5/11/21
|
Sun Y, Wu Y, Bonardi O. et al. | medRxiv
Aim: To compare mental health outcomes assessed during COVID-19 to outcomes prior to COVID-19 in the general population and other population groups.
|
|
|
5/11/21
|
Ling RR, Lim Sim JJ, Tan FL, et al | PROSPERO
|
|
|
5/11/21
|
Jansen D, Vervoort H, Dratva J, et al | PROSPERO
|
|
|
5/11/21
|
Santos M, de Lima Barroso I, da Silva MAX, et al | PROSPERO
|
|
|
5/11/21
|
Alhassane D, Carlos-Bolumbu M, Galtier F | PROSPERO
|
|
|
5/11/21
|
Manheim D, Toomey D, Wiecek W, et al | PROSPERO
|
|
|
5/11/21
|
La Rochelle P, Chauny JM, Daoust R, et al | PROSPERO
|
|
|
5/11/21
|
Smith S, Sui Y, Carter B, et al | PROSPERO
|
|
|
5/11/21
|
Smith S, Sui Y, Carter B, et al | PROSPERO
|
|
|
5/10/21
|
Pensel MC, Fink J | PROSPERO
|
|
|
5/10/21
|
Shirvaliloo M, Sheervalilou R, Baghi HB | PROSPERO
|
|
|
5/10/21
|
Dhanani J, Roberts J | PROSPERO
|
|
|
5/10/21
|
Mattiello R, Scarpatto C, Borba E, et al | PROSPERO
|
|
|
5/10/21
|
| medRxiv
Aim: To estimate the association of obesity with severity (defined as use of invasive mechanical ventilation or intensive care unit admission) and all-cause mortality in coronavirus disease 2019 (COVID-19) patients.
|
|
|
5/10/21
|
Ayerbe L, Forgnone I, Ayis S | PROSPERO
|
|
|
5/10/21
|
Chrystoja B, Shield K, Rehm J, et al | PROSPERO
|
|
|
5/10/21
|
Jeddi SA, Rizi ZT, Bahadori T, et al | PROSPERO
|
|
|
5/10/21
|
Churchill R, Riadi I, Kervin L, et al. | Syst Rev
|
|
|
5/10/21
|
Dahms K, Ansems K, Benstöm C, et al | PROSPERO
|
|
|
5/10/21
|
Ghashghaee A, Kan FP, Rafiei S, et al | PROSPERO
|
|
|
5/10/21
|
Acharya A, Iqbal F, Sounderajah V, et al | PROSPERO
|
|
|
5/10/21
|
Feltham L, Galatis D, Banh HL, et al | PROSPERO
|
|
|
5/10/21
|
Hasan F, Budi HS | PROSPERO
|
|
|
5/10/21
|
Khobragafe A, Agrawal N | PROSPERO
|
|
|
5/10/21
|
Zhu J, Racine N, Eirich R, et al | PROSPERO
|
|
|
5/10/21
|
Peter YTW, Juruena M, Young A | PROSPERO
|
|
|
5/10/21
|
Liu N, Zhang T, Ma L, et al | PROSPERO
|
|
|
5/10/21
|
Velickovic V, Sun S, Abdelaziz AB, et al | PROSPERO
|
|
|
5/10/21
|
The determinants and correlates of physical activity amidst the COVID-19 pandemic in healthy adults.
Smith S, Carter B, Prapavessis H, et al | PROSPERO
|
|
|
5/10/21
|
Zhang L, Wang J, Feng G, et al | PROSPERO
|
|
|
5/10/21
|
Schneider J, Craddock N, Forshaw M, et al | PROSPERO
|
|
|
5/10/21
|
Alboksmaty A, Beany T, Neves AL, et al | PROSPERO
|
|
|
5/7/21
|
Schwendinger F, Pocecco E, Infanger D, et al | PROSPERO
|
|
|
5/7/21
|
Araujo C, Carvalho S, Vêncio E | PROSPERO
|
|
|
5/7/21
|
Prakash H, Kalaiselvi V, Chakravarthy P | PROSPERO
|
|
|
5/7/21
|
Galatis D, Banh HL, Cave A, et al | PROSPERO
|
|
|
5/7/21
|
Ahenda P, Appiah B, Mutayoba B | PROSPERO
|
|
|
5/7/21
|
Bonardi O, Wang Y, Li K, et al. | medRxiv
Aim: To assess effects of mental health interventions for community-based children, adolescents, and adults.
|
|
|
5/7/21
|
Temeng E, Anstey S, Bundy C, et al | PROSPERO
|
|
|
5/7/21
|
Sanfilippo F, Astuto M | PROSPERO
|
|
|
5/7/21
|
Qian Y, Xu H, Diao J, et al. | Medicine
|
|
|
5/7/21
|
Bianco C, Guidet B, Flaatten H, et al | PROSPERO
|
|
|
5/7/21
|
Ribeiro T, Herdeiro MT, Roque F, et al | PROSPERO
|
|
|
5/7/21
|
Ribeiro T, Roque F, Herdeiro MT, et al | PROSPERO
|
|
|
5/7/21
|
Morales-Cane I, del Rocío VL, López-Soto PJ | PROSPERO
|
|
|
5/7/21
|
Suelves JM, Gomez-Zuñiga B, Armayones M | PROSPERO
|
|
|
5/7/21
|
Weerasekara I, Pathirana M, Kalhari R, et al | PROSPERO
|
|
|
5/6/21
|
Mangoni A, Zinelli A | PROSPERO
|
|
|
5/6/21
|
Song W, Wangwang K | PROSPERO
|
|
|
5/6/21
|
Gil-Rodrigo A, Llorens P, Martínez-Buendía, et al | PROSPERO
|
|
|
5/6/21
|
Dilokthornsakul P, Thakkinstian A, Hutubessy R, et al | PROSPERO
|
|
|
5/6/21
|
Cicolini G, Simonetti V, Comparcini D, et al | PROSPERO
|
|
|
5/6/21
|
Hamza SB, Abdalla YA, Mustafa AAM, et al | PROSPERO
|
|
|
5/6/21
|
Drea A, Nangare C | PROSPERO
|
|
|
5/6/21
|
| Cochrane COVID Rapid Reviews
|
|
|
5/6/21
|
Torres AA, Jonathan C | PROSPERO
|
|
|
5/6/21
|
de Oliveira Silva DF, Cobucci RN, Lima SCVC, et al. | medRxiv
Aim: To identify the prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic. UPDATED
|
|
|
5/6/21
|
Zhao H, Huang S, Mei K, et al. | medRxiv
Aim: To review the evidence on the effects of non-steroidal anti-inflammatory drugs in patients with COVID-19.
|
|
|
5/6/21
|
Cruz-Ausejo L, Villarreal-Zegarra D, Reátegui-Rivera CM, et al | PROSPERO
|
|
|
5/6/21
|
Dzinamarira T, Mhango M, Dzobo M, et al. | PLoS One
|
|
|
5/6/21
|
Zhou X, Zhong L, Wang W, et al | PROSPERO
|
|
|
5/5/21
|
Meixueiro VHO, Campos EP | PROSPERO
|
|
|
5/5/21
|
Patra P, Das RR, Chaudhary H, et al | PROSPERO
|
|
|
5/5/21
|
Saragih ID, Saragih IS, Tonapa SI | PROSPERO
|
|
|
5/5/21
|
Throne T, Estabrooks C | PROSPERO
|
|
|
5/5/21
|
Prabani KIP, Damayanthi HDWT | PROSPERO
|
|
|
5/5/21
|
Little T, Reinhard D, White S | PROSPERO
|
|
|
5/5/21
|
Niemi M, Flodi P, Osika W, et al | PROSPERO
|
|
|
5/5/21
|
Silva F, Stein A, Lima J, et al | PROSPERO
|
|
|
5/5/21
|
Badenoch J, Rengasamy ER, Watson CJ, et al. | medRxiv
Aim: To determine the prevalence of neuropsychiatric symptoms in survivors of COVID-19. UPDATED
|
|
|
5/5/21
|
Leal Cortez AC, Dantas EHM | PROSPERO
|
|
|
5/5/21
|
Di Liberto A, Biagianti B, Aiello N, et al | PROSPERO
|
|
|
5/5/21
|
SARS-CoV2 pandemic effects on healthcare workers' mental health: Systematic review and meta-analysis
Aymerich C, Pedruzo B, Andres L, et al | PROSPERO
|
|
|
5/5/21
|
Austin M, Gersberg R | PROSPERO
|
|
|
5/5/21
|
Csupor D, Toth B, Matuz M, et al | PROSPERO
|
|
|
5/5/21
|
Zhang CN, Jiahui L | PROSPERO
|
|
|
5/5/21
|
Zhang C, Jiahui L | PROSPERO
|
|
|
5/5/21
|
Uaprasert N, Panrong K, Chiasakul T | PROSPERO
|
|
|
5/4/21
|
Aasim S, Ahmed S | PROSPERO
|
|
|
5/4/21
|
Benzouak T, Rao S, Gunpat S, et al | PROSPERO
|
|
|
5/4/21
|
Vedovati MC, Graziani M, Becattini C | PROSPERO
|
|
|
5/4/21
|
Leonart L, Pontarolo R, Ribeiro M, et al | PROSPERO
|
|
|
5/4/21
|
Saragih ID, Saragih IS | PROSPERO
|
|
|
5/4/21
|
Melo dos Santos AC, Farias KF, de Seuza Figueiredo | PROSPERO
|
|
|
5/4/21
|
Sidarta C, Kurniawan A | PROSPERO
|
|
|
5/4/21
|
Fei Z, Chen Z, Du X, et al | PROSPERO
|
|
|
5/4/21
|
Molteni A, Manfredi M, Ghulam A, et al | PROSPERO
|
|
|
5/4/21
|
Özkan I, Taylan S | PROSPERO
|
|
|
5/4/21
|
Meyer D, Ogungbe B, Farley J | PROSPERO
|
|
|
5/4/21
|
Waqar U, Ahmed S, Hussain A, et al | PROSPERO
|
|
|
5/4/21
|
Mueller A, Skoetz N, Piechotta V, et al | PROSPERO
|
|
|
5/3/21
|
Khodayari-Zarnaq R, Dehghani A, Azami-Aghdash S, et al | PROSPERO
|
|
|
5/3/21
|
Kotfis K, Skonieczna-?ydecka K, ?oniewski I, et al | PROSPERO
|
|
|
5/3/21
|
Lu C, Dong F, Liu H, et al | PROSPERO
|
|
|
5/3/21
|
Coclite D, Napoletano A, Iannone P, et a | PROSPERO
|
|
|
5/3/21
|
Hugh-Jones S, Prabhu S, Podiya JK, et al | PROSPERO
|
|
|
5/3/21
|
Hugh-Jones S, Prabhu S, Podiya JK, et al | PROSPERO
|
|
|
4/30/21
|
Parthasarathi A, Mahesh PA, Padukudru S, et al | PROSPERO
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
Wang J, Liu K, Zhang L | PROSPERO
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
Cashman A, Murphy M | PROSPERO
|
|
|
4/30/21
|
Ting Wong TH, Liang W, Luo S, et al | PROSPERO
|
|
|
4/30/21
|
Nursanti I, Yunitri N, Kurwiyah N, et al | PROSPERO
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
Sousa G, Galvão-Coelho N, Tavares V, et al | PROSPERO
|
|
|
4/30/21
|
Carnauba ATL, da Costa KVT, Madeiro LB, et al | PROSPERO
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/30/21
|
Barlinn K, Siepmann T, Sedghi A, et al | PROSPERO
|
|
|
4/30/21
|
Faruque M, Laine M, Bikker F | PROSPERO
|
|
|
4/30/21
|
Cassimiro Inacio ML, Mendes LL, Borges LD, et al | PROSPERO
|
|
|
4/30/21
|
Damara F, Faried A | PROSPERO
|
|
|
4/30/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/29/21
|
Deb P, Bhuiyan AH, Talukder S, et al | PROSPERO
|
|
|
4/29/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/29/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/29/21
|
Nunes ML, Richter S, Wearick-Silva LE | PROSPERO
|
|
|
4/29/21
|
Alves DE, Rogeberg O, Mamelund SE | PROSPERO
|
|
|
4/29/21
|
Rahman MM, Chowdhury U, Hasan MN, et al | PROSPERO
|
|
|
4/29/21
|
Balanzá-Martínez V, Méndez R, Grevet EH, et al | PROSPERO
|
|
|
4/29/21
|
Hessami K, Shamshirsaz A | PROSPERO
|
|
|
4/29/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/29/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/29/21
|
Ayosanmi O, Akingbule O, Akingbule A, et al | PROSPERO
|
|
|
4/29/21
|
Jiao B, Chen M | PROSPERO
|
|
|
4/29/21
|
D'Andrea N, Saccomanno S, Quinzi V, et al | PROSPERO
|
|
|
4/29/21
|
| Cochrane COVID Rapid Reviews
|
|
|
4/29/21
|
Grealish A, Tzouvara V, DeRijik L, et al | PROSPERO
|
|
|
4/28/21
|
Yang S, Tsai SHL | PROSPERO
|
|
|
4/28/21
|
Xu J, Noorbhai L, Patel A, et al | PROSPERO
|
|
|
4/28/21
|
Kunzler AM, Roethke N, Lindner S, et al | PROSPERO
|
|
|
4/28/21
|
Kunzler AM, Roethke N, Lindner S, et al | PROSPERO
|
|
|
4/28/21
|
Parthasarathi A, Puvvada R, Padukudru S, et al | PROSPERO
|
|
|
4/28/21
|
Walker E, Hood A, Kirkham F | PROSPERO
|
|
|
4/27/21
|
Rao S, Benzouak T, Gunpat S, et al. | medRxiv
Aim: To evaluate the prevalence of fatigue in post-recovery from SARS-CoV-2 infection. UPDATED
|
|
|
4/27/21
|
Podmore B, Qizilbash N, Lacetera A, et al. | medRxiv
Aim: To summarise and compare evidence from randomised controlled trials and observational studies of the effect of tocilizumab on in-hospital mortality in patients with COVID-19. UPDATED
|
|
|
4/26/21
|
Burton G, Carver H, Parkes T, et al | PROSPERO
|
|
|
4/26/21
|
Wang T, Wang M, Yang D | PROSPERO
|
|
|
4/26/21
|
Alqahtani S, Abdul Razack HI, Mathew S, et al | PROSPERO
|
|
|
4/26/21
|
Dolz del Castellar B, Lara E, Castelletti C, et al | PROSPERO
|
|
|
4/26/21
|
Li L, Moosbrugger M | PROSPERO
|
|
|
4/26/21
|
Luo X, Lv M, Yang B, et al | PROSPERO
|
|
|
4/26/21
|
Bossard M, Kofler T, Kurmann R, et al | PROSPERO
|
|
|
4/26/21
|
Eslami G, Markowitz J, Moradimajd P, Samaee H, et al | PROSPERO
|
|
|
4/26/21
|
Meng X, Liu Y, Huang X, et al | PROSPERO
|
|
|
4/26/21
|
Zhang S, Chen Z | PROSPERO
|
|
|
4/26/21
|
Misra S, Kolappa K, Prasad M, et al. | MedRxiv
Aim: To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality. UPDATED
|
|
|
4/26/21
|
Iness Audra, Cockburn C, Cyrus J, et al | PROSPERO
|
|
|
4/26/21
|
Marchand G, Ware K, Taher A, et al | PROSPERO
|
|
|
4/26/21
|
El Hayek G, Berry I, Wong B, et al | PROSPERO
|
|
|
4/26/21
|
Sliwka A, Kaszuba M, Pilinski R, et al | PROSPERO
|
|
|
4/26/21
|
Purwanti OS, Sudaryanto A | PROSPERO
|
|
|
4/26/21
|
Bai Y, Yan Z, Murray EJ | medRxiv
Aim: To review the literature on COVID-19 and ABO blood type to assess the quality of the evidence for or against a relationship between ABO blood type and COVID-19 risk and severity.
|
|
|
4/26/21
|
Shah R, Dhital R, Carmina S | PROSPERO
|
|
|
4/26/21
|
Maharani A, Sujarwoto S, Tampubolon G, et al | PROSPERO
|
|
|
4/26/21
|
Vinade Chagas ME, Junqueira D, Wienekiewicz S, et al | PROSPERO
|
|
|
4/23/21
|
Kamarullah W, Sabrina AP, Rocky MA, et al | PROSPERO
|
|
|
4/23/21
|
Sakthivel M, Rubeshkumar P, Ganeshkumar P, et al | PROSPERO
|
|
|
4/23/21
|
Katzenschlager S, Denkinger C, Brümmer L, et al | PROSPERO
|
|
|
4/23/21
|
Dayan V, Florio L, Vignolo G, et al | PROSPERO
|
|
|
4/23/21
|
Reis S, Morais C, Valente E, et al | PROSPERO
|
|
|
4/23/21
|
Price R, Kelly C, Macleod U, et al | PROSPERO
|
|
|
4/23/21
|
Jennings G, Romero-Ortuño R, Monaghan A, et al | PROSPERO
|
|
|
4/23/21
|
Corrêa F, Nascimento A, Ribeiro L | PROSPERO
|
|
|
4/23/21
|
Lee KW, Ooi PB | PROSPERO
|
|
|
4/23/21
|
| PROSPERO
|
|
|
4/22/21
|
Dawson A, Pemble C, Brown T, et al | PROSPERO
|
|
|
4/22/21
|
Peng A, Sun B, He Y | PROSPERO
|
|
|
4/22/21
|
Peng D, Li J | PROSPERO
|
|
|
4/22/21
|
Palaiodimou L, Stefanou MI, Katsanos A, et al. | PROSPERO
|
|
|
4/22/21
|
Chakafana G, Aremu O, Mutithu D, et al | PROSPERO
|
|
|
4/22/21
|
Silveira I, Loureiro S | PROSPERO
|
|
|
4/22/21
|
Olorunda O, Henderson K, Okoro K, et al | PROSPERO
|
|
|
4/22/21
|
Selvarajan S, Anandaradje A, Shivabasappa S, et al | PROSPERO
|
|
|
4/22/21
|
Huang K, Lou S | PROSPERO
|
|
|
4/22/21
|
Van Dusen R, Abernethy K, Kurmi O | PROSPERO
|
|
|
4/22/21
|
Scquizzato T, D'Amico F, Rocchi M, et al | PROSPERO
|
|
|
4/22/21
|
Zhang P, Harnegie MP, Alwakeel M, et al | PROSPERO
|
|
|
4/22/21
|
Nascimento L, Fregonezi G, Torre-Castro R, et al | PROSPERO
|
|
|
4/22/21
|
XiaLi X, Zhongyi D, Ning L, et al | PROSPERO
|
|
|
4/22/21
|
Hajissa K, Islam A, Mohamed Z, et al | PROSPERO
|
|
|
4/22/21
|
Gan L, Tan J, Zhang D | PROSPERO
|
|
|
4/22/21
|
Pong J, Frengopoulos C | PROSPERO
|
|
|
4/21/21
|
Alharbi M, Alharbi A | PROSPERO
|
|
|
4/21/21
|
Fazzini b, Puthucheary Z, Page A | PROSPERO
|
|
|
4/21/21
|
de Barros Gonze B, di Paschoale Ostolin TLV | PROSPERO
|
|
|
4/21/21
|
Wadnerkar-Kamble M, Campbell R, Curran E, et al | PROSPERO
|
|
|
4/21/21
|
Bacaro V, Meneo D, Martoni M, et al | PROSPERO
|
|
|
4/20/21
|
Moura S, Oliveira R, Cruz L, et al | PROSPERO
|
|
|
4/20/21
|
Khawaja A, Ali R, Ather M, Kim M, et al | PROSPERO
|
|
|
4/20/21
|
Gama RKB, de Oliveira MML, dos Santos ACM, et al | PROSPERO
|
|
|
4/20/21
|
Wu Y, Zhang G, | PROSPERO
|
|
|
4/20/21
|
Fan M, Guo D, Zhao J | PROSPERO
|
|
|
4/20/21
|
Meena JP, Gupta AK, Haldar P | PROSPERO
|
|
|
4/20/21
|
Meena JP, Gupta AK, Haldar P | PROSPERO
|
|
|
4/20/21
|
Moreira DC, Dieter C, Lemos NE, et al | PROSPERO
|
|
|
4/20/21
|
Tan R, Chua EX, Hasan S, et al | PROSPERO
|
|
|
4/20/21
|
Moniz M, Pereira S, Leite A | PROSPERO
|
|
|
4/20/21
|
Hamada Y, Rangaka M, Papineni P, et al | PROSPERO
|
|
|
4/20/21
|
Chen J, Farah N, Dong RK, et al. | medRxiv
Aim: To provide a systematic review and meta-analysis on the prevalence rates of mental health symptoms of anxiety, depression, and insomnia among the major populations during the COVID-19 pandemic in Africa.
|
|
|
4/19/21
|
Singh AK, Kumar A, Sharma M, et al | PROSPERO
|
|
|
4/19/21
|
Zhang S, Qin X, Tan B, et al | PROSPERO
|
|
|
4/19/21
|
Carcaillon-Bentata L, Makovski T, Ghattas J, et al | PROSPERO
|
|
|
4/19/21
|
Miles B, Saville C | PROSPERO
|
|
|
4/19/21
|
England R, Kumar E, Zohoori V, et al | PROSPERO
|
|
|
4/19/21
|
Betthaeuser BA, Bach-Mortensen AM, Engzell P | PROSPERO
|
|
|
4/19/21
|
Shah V, Binnicker M, Yao J, et al | PROSPERO
|
|
|
4/19/21
|
Urši? A, Kukec A, Vracko P | PROSPERO
|
|
|
4/19/21
|
Wei H, Li S, O'Toole T, Yu M, et al | PROSPERO
|
|
|
4/19/21
|
Uribe ES, Mancías Guerra CM, Canales NG, et al | PROSPERO
|
|
|
4/19/21
|
Alqahtani J, Oyelade T, Hurst J | PROSPERO
|
|
|
4/19/21
|
Leary LO, Moran F, Kiely D | PROSPERO
|
|
|
4/19/21
|
Fei Z, Chen Z, Du X, et al | PROSPERO
|
|
|
4/19/21
|
Patwary MM, Alam A, Shuvo FK | PROSPERO
|
|
|
4/19/21
|
Santos M, Silva C, Lyra R | PROSPERO
|
|
|
4/19/21
|
Tuina (massage) therapy for insomnia in COVID-19: a protocol for systematic review and meta-analysis
Meng M, Hu G, Yang K, et al | PROSPERO
|
|
|
4/18/21
|
Miniati M , Marzetti F, Palagini L, et al | medRxiv
Aim: To summarize present literature on COVID pandemic and eating disorders.
|
|
|
4/16/21
|
Chong W, Saha B | PROSPERO
|
|
|
4/16/21
|
Alsaif F, Wright D, Patel A, et al. | PROSPERO
|
|
|
4/16/21
|
Martha J, Pranata R, Lim M | PROSPERO
|
|
|
4/16/21
|
Shahhosseini Z, Hajimohammadreza M, Mohammadi KM, et al. | PROSPERO
|
|
|
4/16/21
|
Motlagh RS, Abufaraj M, Karakiewicz P, et al. | PROSPERO
|
|
|
4/16/21
|
Li H, Yang J, Yan B | PROSPERO
|
|
|
4/16/21
|
Edington F, Gadelha S, Santiago M, et al. | PROSPERO
|
|
|
4/16/21
|
Calderon DA, Suen HYG | PROSPERO
|
|
|
4/16/21
|
Ollila HM, Partinen M, Koskela J, et al. | medRxiv
Aim: To examine the effect of face mask intervention in respiratory infections across different exposure settings and age groups.
|
|
|
4/16/21
|
Fowler K, Robbins L | PROSPERO
|
|
|
4/16/21
|
Hernandez-Garn M, Erlacher V, Mezes B | PROSPERO
|
|
|
4/16/21
|
Alharbi M, Alharbi A | PROSPERO
|
|
|
4/16/21
|
Al-Nabahin A, Drid B, Alagelli F, et al. | PROSPERO
|
|
|
4/16/21
|
Kotlar B, Rolnik D, Denduluri A, Mark T, et al. | PROSPERO
|
|
|
4/16/21
|
Cordoves RA, Rivera K | PROSPERO
|
|
|
4/15/21
|
Chen J, Zhang SX, Xu W, et al. | medRxiv
Aim: To review and assess the prevalence of anxiety, depression, and insomnia symptoms in the general population, frontline healthcare workers (HCWs), and adult students in Spain during the COVID-19 crisis. UPDATED
|
|
|
4/15/21
|
Alharbi M, Alharbi A | PROSPERO
|
|
|
4/15/21
|
Ponsford M, Ward TJC, Stoneham S, et al | PROSPERO
|
|
|
4/15/21
|
Vieira CC, da Donseca Orcina B, Brito Reia VC, da Silva Santos PS | PROSPERO
|
|
|
4/15/21
|
Sarkar PG, Kumar A | PROSPERO
|
|
|
4/15/21
|
Alfonso-Castillo G, Pinoti R | PROSPERO
|
|
|
4/15/21
|
Deng H, Yan X, Yuan L, et al | PROSPERO
|
|
|
4/15/21
|
Batra K, Batra R, Sharma M, et al | PROSPERO
|
|
|
4/15/21
|
Pickford R, Woeckel M, Schneider A, et al | PROSPERO
|
|
|
4/15/21
|
Giebel C, Talbot C, Thyrian JR, et al | PROSPERO
|
|
|
4/15/21
|
Cui H, He H, Fan R, et al | PROSPERO
|
|
|
4/15/21
|
Souza KS, da Silva MRF, de Pinto Brito B, Ferreira Rocha FL, et al | PROSPERO
|
|
|
4/14/21
|
Peña R, Osorip C | PROSPERO
|
|
|
4/14/21
|
Zheng Y, Wang L, Zhu Y, et al. | Medicine
|
|
|
4/14/21
|
Sahebi A, Golitaleb M | PROSPERO
|
|
|
4/14/21
|
Pang JK, Jones SP, Waite LL, et al. | medRxiv
Aim: To estimate the probability of an infectious index passenger in the air travel system transmitting the SARS-CoV-2 virus to a fellow passenger during air travel.
|
|
|
4/14/21
|
Wang X, Wang Y, Liang L | Medicine
|
|
|
4/13/21
|
Wang YL, Zhang M | PROSPERO
|
|
|
4/13/21
|
Wang J, Su K, Qi L, et al | PROSPERO
|
|
|
4/13/21
|
Rajendran V, Chenna D, Kamdasamy D, et al | PROSPERO
|
|
|
4/13/21
|
Audrey J, Tahapary D | PROSPERO
|
|
|
4/13/21
|
Guo P, Begum T, Efstathiou N, et al | PROSPERO
|
|
|
4/13/21
|
Sebong PH, Pardosi J, Susianto IA, et al | PROSPERO
|
|
|
4/13/21
|
Pan Q, Li M, Jing F, et al | PROSPERO
|
|
|
4/13/21
|
Sakala M, Kambalame DM, Hara H, et al | PROSPERO
|
|
|
4/13/21
|
Wang G, Chen W, Chen X, et al | PROSPERO
|
|
|
4/13/21
|
Gunnarson K, Mathews A, Cao Y, et al | PROSPERO
|
|
|
4/13/21
|
Vásquez AMP, Pérez Delgadillo GM | PROSPERO
|
|
|
4/13/21
|
Tokavanich N, Mongkonsritragoon W | PROSPERO
|
|
|
4/13/21
|
Lima de Sousa E, de Carvalho Saraiva JB, Macedo Santos RS | PROSPERO
|
|
|
4/13/21
|
Kumar A, Munisamy M, Prasad A, et al | PROSPERO
|
|
|
4/13/21
|
Sarkar PG, Kumar A | PROSPERO
|
|
|
4/13/21
|
Zanirati G, Provenzi L, Bizotto S, et al | PROSPERO
|
|
|
4/13/21
|
Heath P, Ikram SI, Sutton N, et al | PROSPERO
|
|
|
4/13/21
|
Woller S, Klok E, de Wit K, et al | PROSPERO
|
|
|
4/13/21
|
Cheng A, Deans R | PROSPERO
|
|
|
4/13/21
|
Hessami K, Shamshirsaz A | PROSPERO
|
|
|
4/12/21
|
Wang Y, Yang X, Chen H, et al. | Medicine
|
|
|
4/12/21
|
Zhour Y, Yan X, Ma F, et al. | Medicine
|
|
|
4/12/21
|
Hoshijima H, Mihara T, Seki H, et al. | medRxiv
Aim: To determine long-term symptoms in COVID-19 survivors after infection. UPDATED
|
|
|
4/9/21
|
Chong W, Saha B, Medarov B | PROSPERO
|
|
|
4/9/21
|
Chong W, Saha B, Chopra A | PROSPERO
|
|
|
4/9/21
|
Ssentongo AE, Ssentongo P, McCall-Hosenfeld, et al | PROSPERO
|
|
|
4/9/21
|
Melgarejo-Castillo AA, Del Villar MAH, Balarezo PIT, et al | PROSPERO
|
|
|
4/9/21
|
De la Rosa-Martinez D, Delaye-Martínez MA, Juárez-Cruz ID, et al | PROSPERO
|
|
|
4/9/21
|
Kotepui M, Wilairatana P, Masangkay FR, et al | PROSPERO
|
|
|
4/9/21
|
Yusof RC, Noor NM, Yacon MA | PROSPERO
|
|
|
4/9/21
|
Major M, Horton S, Majowicz S, et al | PROSPERO
|
|
|
4/9/21
|
Haji-Hassan M, Bolboaca S, Lenghel M | PROSPERO
|
|
|
4/9/21
|
Pinto L, Schaan B | PROSPERO
|
|
|
4/8/21
|
Tam M, Davis V, Ahluwalia M, et al | PROSPERO
|
|
|
4/8/21
|
Nicholas C, Ng CH | PROSPERO
|
|
|
4/8/21
|
Howard R, Manohar H, Sharma A, et al | PROSPERO
|
|
|
4/8/21
|
Reda RM, Refaat R, Ageeb M, et al | PROSPERO
|
|
|
4/8/21
|
Pino-Zavaleta F, Fernández MF, Vasquez-Ramirez N, et al | PROSPERO
|
|
|
4/8/21
|
Da Silva MS, De Morais Gouveia GP, de Sousa Mesquita Silva E, et al | PROSPERO
|
|
|
4/8/21
|
Nothacker J, Schmucker C, Meerpohl J, et al | PROSPERO
|
|
|
4/8/21
|
Crivelli L, Palmer K, Mangialasche F, et al | PROSPERO
|
|
|
4/8/21
|
Chong W, Saha B | PROSPERO
|
|
|
4/8/21
|
Harapan H, Fahriani M, Fajar JK | PROSPERO
|
|
|
4/8/21
|
Montelo ES, de Sousa Mesquita Silva E, de Sousa FA, et al | PROSPERO
|
|
|
4/8/21
|
Pal R, Bhadada SK | PROSPERO
|
|
|
4/8/21
|
O'Donoghue C, Thomas S, Fleming P, et al | PROSPERO
|
|
|
4/8/21
|
Hahne TM, Brushinski E, Drewitz KP, et al | PROSPERO
|
|
|
4/8/21
|
Antonopoulos V, Theocharis A, Christodoulou N | PROSPERO
|
|
|
4/8/21
|
Sharma B, Agarwal N | PROSPERO
|
|
|
4/8/21
|
Obnial JC, Sia NE, Austria JT, et al | PROSPERO
|
|
|
4/8/21
|
Xiao L, Huang S | PROSPERO
|
|
|
4/8/21
|
Kyriakopoulos C, Gogali A, Kostikas K, et al | PROSPERO
|
|
|
4/7/21
|
Simon A, Adera T, Yilma T, et al | PROSPERO
|
|
|
4/7/21
|
Ernst M, Werner AM, Niederer D | PROSPERO
|
|
|
4/7/21
|
Cevik A, Koroglu CO, Karacam Z, et al | PROSPERO
|
|
|
4/7/21
|
Meggiolaro A, Schepisi MS, Siddu A, et al | PROSPERO
|
|
|
4/7/21
|
Shinejil U, Royce R, Lisa J, et al | PROSPERO
|
|
|
4/7/21
|
Iskandarani G, Koshiaris C, Khamis A, et al | PROSPERO
|
|
|
4/7/21
|
Massoud G, Zouein F, Abdulhai F, et al | PROSPERO
|
|
|
4/7/21
|
Verstraeten R, Touré M, Diatta D, et al | PROSPERO
|
|
|
4/6/21
|
Mackintosh E, Truesdale M | PROSPERO
|
|
|
4/6/21
|
Ebrahimi M, Harmooshi NN, Rahim F | medRxiv
Aim: To assess the diagnostic utility of antigen detection rapid diagnostic tests for covid- 19 versus RT-PCR in a different type of samples and different stages of infection determine the usability of rapid tests in best time and sample.
|
|
|
4/6/21
|
Shaikh SZ, Patil A, Langde D | PROSPERO
|
|
|
4/6/21
|
Elsayed HH, Hassaballa AS, Ahmed TA, et al. | Research Square
Aim: To review the evidence on ECMO for COVID-associated ARDS to study its outcome.
|
|
|
4/6/21
|
Pereira FD, Zaidan P, Rosa G | PROSPERO
|
|
|
4/6/21
|
Hur G, Cinar N | PROSPERO
|
|
|
4/5/21
|
Xue X, Deng Z, Li N, et al. | Research Square
|
|
|
4/1/21
|
Le H, Pham T | PROSPERO
|
|
|
4/1/21
|
Murphy A, Kirby A, Drummond F, et al | PROSPERO
|
|
|
4/1/21
|
Cui Y, Li S, Yang Z, et al | PROSPERO
|
|
|
4/1/21
|
Arago G, Soares D, Soares E | PROSPERO
|
|
|
4/1/21
|
Jiao B, Cavayas A, Williamson D, et al | PROSPERO
|
|
|
4/1/21
|
Sin J, Chien WT, Batchelor R, et al | PROSPERO
|
|
|
4/1/21
|
Chen MS, Chen RK, Zheng ZZ, et al | PROSPERO
|
|
|
4/1/21
|
Ung L, Goss D, Hanage W | PROSPERO
|
|
|
4/1/21
|
Prosperini L, Haggiag S, Totorella C, et al | PROSPERO
|
|
|
4/1/21
|
Bitencourt FV, Lia EN, Pauletto P, et al | PROSPERO
|
|
|
4/1/21
|
Karacam Z, Sari E, Yüksel R, Arslanta? H | PROSPERO
|
|
|
4/1/21
|
Wishnuwardhana, Fernandez | PROSPERO
|
|
|
3/31/21
|
Banholzer N, Lison A, Özcelik D, et al | PROSPERO
|
|
|
3/31/21
|
Gonçalves AK, Rodrigues HM, Medeiros K, et al | PROSPERO
|
|
|
3/31/21
|
Boland L, Garcia AJ, Aylward E, et al | PROSPERO
|
|
|
3/31/21
|
Marques T, Cuoto P | PROSPERO
|
|
|
3/31/21
|
Shi C, Wu M | PROSPERO
|
|
|
3/31/21
|
Ozdemir K, Baskaya Y, Sahin S | PROSPERO
|
|
|
3/31/21
|
Ferrari A, Santomauro D, Mantilla-Herrera A, et al | PROSPERO
|
|
|
3/31/21
|
Frank J, Herchenhahn C, Wedekind L, et al | PROSPERO
|
|
|
3/31/21
|
Servais C, De Breuck Y | PROSPERO
|
|
|
3/30/21
|
Clark S, Vindrola C | PROSPERO
|
|
|
3/30/21
|
Sasikumar A, Iype T, Anish T S, et al | PROSPERO
|
|
|
3/30/21
|
Marczak J, Velickovic S, Neddermeyer A, et al | PROSPERO
|
|
|
3/30/21
|
Li J, Liao X, Zhou Y, et al. | Research Square
Aim: To evaluate this potential effect from glucocorticoids treatment for COVID-19.
|
|
|
3/30/21
|
Aragão G, Oliveira S, Moita S | PROSPERO
|
|
|
3/30/21
|
Goncalves AK, Medeiros KS, Macêdo LTA, et al | PROSPERO
|
|
|
3/30/21
|
Gao M, Wang M | PROSPERO
|
|
|
3/30/21
|
Qin X, Teng X, Liu Y, Meichao S, et al | PROSPERO
|
|
|
3/30/21
|
Yang Y, Fang M | PROSPERO
|
|
|
3/30/21
|
Budd G, Griffiths D, Howick J, et al | PROSPERO
|
|
|
3/30/21
|
Kharel M, Sakamoto JL, Carandang RR, et al | PROSPERO
|
|
|
3/30/21
|
Watts T, Anstey S, Bundy C, et al | PROSPERO
|
|
|
3/30/21
|
de Santos LR, Martin MAF | PROSPERO
|
|
|
3/30/21
|
Tashakori-Miyanroudi, Souresafil A, et al | PROSPERO
|
|
|
3/30/21
|
Aggarwal AN, Agarwal R, Dhooria S, et al | PROSPERO
|
|
|
3/30/21
|
Susanti HD, Chung MH | PROSPERO
|
|
|
3/30/21
|
Hickey S, Di Nota P | PROSPERO
|
|
|
3/30/21
|
Burns KEA, Cook D, Rochwerg B, et al | PROSPERO
|
|
|
3/30/21
|
Odonnell J, Pirret A, Hoare K | PROSPERO
|
|
|
3/30/21
|
Du C, Chen B, Ao N, et al | PROSPERO
|
|
|
3/30/21
|
Viana de Sousa NC, da Silva J, de Souza Godinho | PROSPERO
|
|
|
3/29/21
|
Daniels S, Wei H, Denning D, et al | PROSPERO
|
|
|
3/29/21
|
Wong C, Li B, Quon B | PROSPERO
|
|
|
3/29/21
|
Ali S, Uddin SZ, Dewan MN, et al. | medRxiv
Aim: To investigate the effect of corticosteroids on the mortality of patients with respiratory viral infections including SARS-CoV-2, SARS, MERS, and Influenza.
|
|
|
3/29/21
|
Bignardi PR, Castello PA, Aquino BM, et al. | medRxiv
Aim: To assess a possible association between plasma vitamin D levels and mortality in patients with COVID–19.
|
|
|
3/29/21
|
Vásquez AAH, Barrenechea-Pulache A, Comande D, et al. | medRxiv
Aim: To conduct a living systematic review of the clinical evidence regarding the effect of different mouth?rinses on the viral load of SARS?CoV?2 in the saliva of infected patients. UPDATED
|
|
|
3/29/21
|
Bhujel N, Zaheer K, Singh RP | PROSPERO
|
|
|
3/29/21
|
Heneghan CJ, Spencer EA, Brassey J, et al. | F1000Res
Aim: To identify, appraise and summarise the evidence from studies of the role of airborne transmission of SARS-CoV-2
|
|
|
3/29/21
|
Onakpoya IJ, Heneghan CJ, Spencer EA, et al. | F1000Res
Aim: To identify, appraise and summarise the evidence from primary studies and systematic reviews assessing the role of fomites in transmission.
|
|
|
3/29/21
|
Diana L, Zanin E, Bonato M, et al | PROSPERO
|
|
|
3/29/21
|
Donoghue K, Pilling S, Saunders R | PROSPERO
|
|
|
3/26/21
|
Li X, Lu H, Li F, et al | PROSPERO
|
|
|
3/26/21
|
Salem N, Ftouni R, Al Jardali B, et al | PROSPERO
|
|
|
3/26/21
|
Guo Q, Wang J, Wu S, et al | PROSPERO
|
|
|
3/26/21
|
Lau V, Mah G, Odenbach J, et al | PROSPERO
|
|
|
3/26/21
|
Yang D, Tao S, Chen Y, et al | PROSPERO
|
|
|
3/26/21
|
Ju J, Yan C, Wang H, et al. | Medicine
|
|
|
3/26/21
|
Song B, Hu Y | PROSPERO
|
|
|
3/26/21
|
Chavan SA, Al-Zumair M, Maxwell L | PROSPERO
|
|
|
3/26/21
|
Aragao G, Neto OB, Britto D, et al | PROSPERO
|
|
|
3/26/21
|
Mihelcic G, Kukec A, Klanš?ek HJ | PROSPERO
|
|
|
3/26/21
|
Yasuda H, Mayumi T, Okano H | PROSPERO
|
|
|
3/26/21
|
Kumar A, Khan S, Rai A, et al | PROSPERO
|
|
|
3/26/21
|
Mangoni A, Zinellu A | PROSPERO
|
|
|
3/26/21
|
Ali D, Bundy R, Mandy W | PROSPERO
|
|
|
3/26/21
|
Zhong M, Huang W, Tang G, et al | PROSPERO
|
|
|
3/26/21
|
Ling R, Tan WQ, Wen Yeo LH, et al | PROSPERO
|
|
|
3/25/21
|
Zang S, Zhao YH, Chang Q, et al | PROSPERO
|
|
|
3/25/21
|
Joshi R, Khan MA | PROSPERO
|
|
|
3/25/21
|
Thakar A, Goyal M, Panara K, et al | PROSPERO
|
|
|
3/25/21
|
Mahmoudi E, Keykhaei M | PROSPERO
|
|
|
3/25/21
|
Urbina C, Chumpitaz CP, Torres-Slimming P | PROSPERO
|
|
|
3/25/21
|
Kong G, Lim NA, Chin YH | PROSPERO
|
|
|
3/25/21
|
Chen J, Cai Y, Zeng J, et al | PROSPERO
|
|
|
3/25/21
|
de Rivera PC, Barajas A | PROSPERO
|
|
|
3/24/21
|
Crankson S, Pokhrel S, Anokye NK | medRxiv
Aim: To investigate what factors determined the mortality and length of hospitalisation in individuals with COVID-19.
|
|
|
3/24/21
|
Charreau S, Wormser J, Philippart F | PROSPERO
|
|
|
3/24/21
|
Hosseini MS, Akbarzadeh MA, Vaez-Gharamaleki Y, et al | PROSPERO
|
|
|
3/24/21
|
Weston O, Rankin J, Dyer J, et al | PROSPERO
|
|
|
3/23/21
|
Rodrigues P, Tibolla Viero F, Tiollier Weber E, et al | PROSPERO
|
|
|
3/23/21
|
BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review
 Stack M, Sacco K, Castagnoli R, et al. | Research Square
Aim: To evaluate the use of BTK inhibitors (BTKinibs) during COVID-19 and assess how they may affect patient outcomes.
|
|
|
3/23/21
|
Wang X, Yin X | PROSPERO
|
|
|
3/23/21
|
Prakash K, Kumar N, Verma S, et al | PROSPERO
|
|
|
3/23/21
|
Khushnood K, Sultan N, Altaf S | PROSPERO
|
|
|
3/23/21
|
Rosati P, Balduzzi S, Santarsiero S, et al | PROSPERO
|
|
|
3/23/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
3/23/21
|
Kang Y, Li X, Wei W, et al | PROSPERO
|
|
|
3/23/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
3/23/21
|
Khalil C, Soni V, Englesakis M, et al | PROSPERO
|
|
|
3/22/21
|
Espinoza-Espinoza DA, Dulanto-Vargas JA, Caceres-La Torre OA, et al | PROSPERO
|
|
|
3/22/21
|
Perroud J, Soldano S, Avanseña A, et al | PROSPERO
|
|
|
3/22/21
|
Dhada S, Stewart D, Cheema E, et al. | medRxiv
Aim: To examine patients’ and caregivers’ experiences of accessing cancer services during the COVID-19 pandemic and perceived impact of the pandemic on their psychological wellbeing. UPDATED
|
|
|
3/22/21
|
Silverii GA, Dicembrini I, Mannucci E, et al | PROSPERO
|
|
|
3/22/21
|
McGing RM, Perinpanathan T, Barlow G, et al | PROSPERO
|
|
|
3/22/21
|
Zhao J, Guo D, Liu Y | PROSPERO
|
|
|
3/22/21
|
Viero FT, Rodrigues P, Kudsi SQ, et al | PROSPERO
|
|
|
3/22/21
|
Viero FT, Rodrigues P, Waldraff H, et al | PROSPERO
|
|
|
3/22/21
|
Letourneau N, Leite F, Hayden A, et al | PROSPERO
|
|
|
3/22/21
|
Toubasi A, Alsayegh T, Obaid Y, et al | PROSPERO
|
|
|
3/22/21
|
Gonçalves AK, Medeiros K, Costa APF, et al | PROSPERO
|
|
|
3/22/21
|
Hu P, Zhang D, Zhu Y, et al | PROSPERO
|
|
|
3/22/21
|
Nash N, Whittle C, Whitmarsh L, et al | PROSPERO
|
|
|
3/22/21
|
Suarez-Gonzalez A, Rajagopalan J, Livingston G, et al. | medRxiv
Aim: To examine and summarise the global research evidence describing the effect of Covid-19 isolation measures on the health of people living with dementia. UPDATED
|
|
|
3/22/21
|
Morales MB, Ortiz-Munoz L, Anselmi GD, et al. | Health Sci Rep
|
|
|
3/19/21
|
Wiens A, Tonin FS, Leonart LP, et al | PROSPERO
|
|
|
3/19/21
|
Rayanakorn A, Chaiprom P, Huey Lee SW | PROSPERO
|
|
|
3/19/21
|
Banh HL, Hu Y, Kung J, et al | PROSPERO
|
|
|
3/19/21
|
Tolton R, Langley T, Bastounis A | PROSPERO
|
|
|
3/19/21
|
Stroehlein J, Griesel M, Popp M, et al | PROSPERO
|
|
|
3/19/21
|
Ningning Y, Fuhai W | PROSPERO
|
|
|
3/19/21
|
Raimundo R, da Assunção Morais e Cunha Vaz Patto M, Pinto | PROSPERO
|
|
|
3/19/21
|
Teixeira K, Lisboa J, Ferreira R, et al | PROSPERO
|
|
|
3/19/21
|
Højberg AM, Henriksen TB, Gjerløv AS | PROSPERO
|
|
|
3/19/21
|
Nunes MJM, Araújo DP | PROSPERO
|
|
|
3/18/21
|
Pejman A, Aghaei L, Salajeghe T, et al | PROSPERO
|
|
|
3/18/21
|
Billings J, Ching BCF, Gkofa V, et al. | medRxiv
Aim: To review the evidence on the experiences of frontline healthcare workers and their views about psychosocial support during the COVID-19 or comparable pandemics.
|
|
|
3/18/21
|
Scquizzato T, Landoni G, Zangrillo A | PROSPERO
|
|
|
3/18/21
|
Galvis LMR, Carcamo SP, Ocampo SS, Lopez AS, et al | PROSPERO
|
|
|
3/18/21
|
Ruvinsky S, Voto C, Fustiñana A, et al | PROSPERO
|
|
|
3/18/21
|
Fabbri L, Moss S, Khan F, et al. | medRxiv
Aim: To assess the prevalence of long term radiological and functional pulmonary sequelae in survivors from COVID-19 and other viral pneumonia in published literature. UPDATED
|
|
|
3/18/21
|
Sampaio L, Medrado A | PROSPERO
|
|
|
3/18/21
|
Ding Y, Guo C, Yu S, et al. | Medicine
|
|
|
3/18/21
|
Hannah J, Galloway J, Bechman K, et al | PROSPERO
|
|
|
3/18/21
|
Jie AJ, Doshi K, Sultana R, et al | PROSPERO
|
|
|
3/18/21
|
Aletreby WT, Abdulrahman B, Mady AF, et al. | medRxiv
Aim: To perform a systematic literature review and meta-analysis of RCTs utilizing Tocilizumab in the treatment of COVID 19 pneumonia, with in hospital mortality as a primary objective, while secondary objectives included composite outcome of mortality, intubation, or ICU admission, another secondary outcome was super added infection.
|
|
|
3/18/21
|
Viner R, Waddington C | PROSPERO
|
|
|
3/18/21
|
Banh HL, Hu Y, Kung J, et al | PROSPERO
|
|
|
3/18/21
|
Grady M, Hayton C, Meyrick J, | PROSPERO
|
|
|
3/16/21
|
Li GF, Yu G, An XX, et al | PROSPERO
|
|
|
3/16/21
|
Ahmed B, Yousaf Z, Ata F, et al | PROSPERO
|
|
|
3/16/21
|
Cruciani M, Pati I, Maimone P, et al | PROSPERO
|
|
|
3/16/21
|
Martins J, Lucchetta R, Mastroianni P | PROSPERO
|
|
|
3/16/21
|
Beck R, Brennan T, Tarantino G, et al | PROSPERO
|
|
|
3/16/21
|
Zhao-chen JI, Hu Hy, Jun-hua Z, et al | PROSPERO
|
|
|
3/16/21
|
Sharma R, Sharma R | PROSPERO
|
|
|
3/16/21
|
Mariano L, Monteiro LM, André L | PROSPERO
|
|
|
3/16/21
|
Fisher J, Chang YS, Winn L, et al | PROSPERO
|
|
|
3/16/21
|
Hussain B, Latif A, Timmons S, et al | PROSPERO
|
|
|
3/16/21
|
Yang Z, Zhang S | PROSPERO
|
|
|
3/16/21
|
Tong ZX, Hui L, Ming HS | PROSPERO
|
|
|
3/16/21
|
XuTong Z, Tian LT, Hui L | PROSPERO
|
|
|
3/16/21
|
Damara F, Soetedjo N | PROSPERO
|
|
|
3/16/21
|
Wardani Y, Santri IN, Sustani EW, et al | PROSPERO
|
|
|
3/16/21
|
Kan C, Sun X, Hou N, et al | PROSPERO
|
|
|
3/16/21
|
García VS, Rincón JMR | PROSPERO
|
|
|
3/16/21
|
Ghulam A, Gianfagna F, Bonaccio M, et al | PROSPERO
|
|
|
3/16/21
|
Shankar A, Agustina R, Rianda D, et al | PROSPERO
|
|
|
3/16/21
|
Maraqa B, Nazzal Z, Al Hroub T, Abu Alia W, et al | PROSPERO
|
|
|
3/16/21
|
Grieve K, McClatchey K, Jackson T | PROSPERO
|
|
|
3/15/21
|
Karki R, Annane D, Paoletti X, et al | PROSPERO
|
|
|
3/15/21
|
Tan RQ, Li WTV, Shum W, et al. | Syst Rev
|
|
|
3/15/21
|
Elshenawy RA, Aslanpour Z, Umaru N | PROSPERO
|
|
|
3/15/21
|
Thomas C, Williams L, Dhandapani A, et al | PROSPERO
|
|
|
3/15/21
|
Rottler M, Leiner T, Virag M, et al | PROSPERO
|
|
|
3/15/21
|
Lou L, Zhang H, Tang B, et al. | medRxiv
Aim: To conduct a comprehensive systematic evaluation and meta-analysis of the clinical characteristics of COVID-19 in children and adolescents to better guide the response to the current epidemic.
|
|
|
3/15/21
|
Broger T, Dekinger CM, Olaru ID, et al | PROSPERO
|
|
|
3/15/21
|
Neldi V, Yulistiani Y, Suprapti B, et al | PROSPERO
|
|
|
3/15/21
|
Middleton S, McKeever TM, Bolton CE | PROSPERO
|
|
|
3/15/21
|
Liu CY, Berlin J, Kiti MC, et al. | medRxiv
Aim: To synthesize empirical data on the changing social contact patterns during the COVID-19 pandemic.
|
|
|
3/15/21
|
Tao Z, Cheng B, Zhou T | PROSPERO
|
|
|
3/15/21
|
Mahboob A, Onwumeh-Okwundu JD, Khan R, et al | PROSPERO
|
|
|
3/15/21
|
Lou L, Zhang H, Li Z, et al. | medRxiv
Aim: To evaluate the effect and safety of remdesivir in the treatment of patients with COVID-19, and will provide a reliable reference for the treatment of COVID-19.
|
|
|
3/15/21
|
Celik I, Bektas M, Duran S | PROSPERO
|
|
|
3/15/21
|
Indarto F, Koerniawan HS, Limas PI | PROSPERO
|
|
|
3/15/21
|
Saleki K, Pourahmad R, Yaribash S, et al | PROSPERO
|
|
|
3/15/21
|
Hannemann K, Abdalrahman A, Albus C | PROSPERO
|
|
|
3/15/21
|
Ziegler E, Rietkoetter S, Bryant-Lukosius D, et al | PROSPERO
|
|
|
3/12/21
|
Muthuka J, Muchiri F, Ngeno L | PROSPERO
|
|
|
3/12/21
|
Antunes ML, Couto P, Marques T, et al | PROSPERO
|
|
|
3/12/21
|
Mahat RK, Rathore V, Swain S, Panda S, et al | PROSPERO
|
|
|
3/12/21
|
Perez-Lopez FR, Pérez-Roncero G, López-Baena M | PROSPERO
|
|
|
3/12/21
|
Harapan H, Fahriani M, Fajar JK, et al | PROSPERO
|
|
|
3/12/21
|
Li Z, Yin M, Xu T, et al | PROSPERO
|
|
|
3/12/21
|
Estenson L, Kim N, Jacobson M, et al | PROSPERO
|
|
|
3/12/21
|
Larson EA, Bader-Larsen K, Magkos F | PROSPERO
|
|
|
3/11/21
|
Viero FT, Rodrigues P, Mazzochi N, et al | PROSPERO
|
|
|
3/11/21
|
Shellenberger R, Mayo M, Potugari B, et al | PROSPERO
|
|
|
3/11/21
|
Tavares-Junior JW, Braga-Neto P, de Souza ACC, et al | PROSPERO
|
|
|
3/11/21
|
Zeng L, Yang K, Chen H | PROSPERO
|
|
|
3/11/21
|
Zeng L, Yang K, Chen H | PROSPERO
|
|
|
3/11/21
|
Zeng L, Yang K, Chen H | PROSPERO
|
|
|
3/11/21
|
Yang F, Li J, Huang W | PROSPERO
|
|
|
3/11/21
|
Zhang Q, Huang J, Liu X, et al | PROSPERO
|
|
|
3/11/21
|
da Silva Magalhães, Nascimento Maniçoba ACB | PROSPERO
|
|
|
3/11/21
|
Li F, Liang W, Yi L, | PROSPERO
|
|
|
3/11/21
|
Li Y, Yang M, Wei S | PROSPERO
|
|
|
3/11/21
|
Wu B, Tao S, Lu Y | PROSPERO
|
|
|
3/11/21
|
Liang H, Song Z, Yuan H | PROSPERO
|
|
|
3/11/21
|
Julianty SA, Anggriani A, Habibe H, et al | PROSPERO
|
|
|
3/11/21
|
Karki SJ, Lange B, Heinsohn T, Joachim A | PROSPERO
|
|
|
3/10/21
|
Alizadeh-Navaei R, Golpur M, Valadan R, et al. | Research Square
Aim: To assess the co-infection of SARS-CoV-2 with influenza among COVID-19 cases.
|
|
|
3/10/21
|
Gesaka R, Ombimbo M | PROSPERO
|
|
|
3/10/21
|
Gao Y, Zhang Z, Cui H | PROSPERO
|
|
|
3/10/21
|
Zhang P, Xie L, Gong J | PROSPERO
|
|
|
3/10/21
|
Lu Y, Wu S, Wu B | PROSPERO
|
|
|
3/10/21
|
Li J, Huang W, Yang F | PROSPERO
|
|
|
3/10/21
|
Zhou L, Liu T, Meng K | PROSPERO
|
|
|
3/10/21
|
Creavin S, Garg M, Hay A | PROSPERO
|
|
|
3/10/21
|
Boden M, Cohen N, Froelich J, et al. | medRxiv
Aim: To review the evidence on whether mental disorder prevalence: (a) was elevated among populations impacted by coronavirus pandemics (relative to unselected populations reported in the literature), and (b) varied by disorder (undistinguished psychiatric morbidity, anxiety, depressive, posttraumatic stress disorders [PTSD]) and impacted population (community, infected/recovered, healthcare provider, quarantined).
|
|
|
3/10/21
|
Gnoato Zotz TG, Santos A, Kus J, et al | PROSPERO
|
|
|
3/10/21
|
Roveron DL, Gonçalves dos Santos IL, Gonçalves dos Santos JL, et al | PROSPERO
|
|
|
3/10/21
|
Vartha SB, Krishna H, Vishwajeet V, et al | PROSPERO
|
|
|
3/10/21
|
Harries M, Lange B, Dreier M | PROSPERO
|
|
|
3/10/21
|
Sen LT, Valeria M, Tri Indraswari M | PROSPERO
|
|
|
3/10/21
|
Tan M, Blaskova A, Bath S, et al | PROSPERO
|
|
|
3/10/21
|
Wang M, Zhai J, Song Z | PROSPERO
|
|
|
3/10/21
|
Zhu X, Cui J, Xu B | PROSPERO
|
|
|
3/10/21
|
Riches S, Hammond N | PROSPERO
|
|
|
3/9/21
|
Robinson E, Sutin AR, Daly M, et al. | medRxiv
Aim: To quantify the size of the mental health burden associated with the pandemic and how this burden changed over time. UPDATED
|
|
|
3/9/21
|
Wang L, Yang LM | PROSPERO
|
|
|
3/9/21
|
Gupta A, Kovoor J, Ovenden C, et al | PROSPERO
|
|
|
3/9/21
|
Yu X, Du L, Ma Y | PROSPERO
|
|
|
3/9/21
|
Meng L, Wang D, Li M | PROSPERO
|
|
|
3/9/21
|
Gu M, Lu P, Yang X | PROSPERO
|
|
|
3/9/21
|
Yuan H, Song Z, Liang H | PROSPERO
|
|
|
3/9/21
|
Yang M, Li Y, Wei S | PROSPERO
|
|
|
3/9/21
|
Hailat R, Thompson R, Goralski T, et al | PROSPERO
|
|
|
3/9/21
|
Oliveira M, Sudati IP, Konzen VM, et al | PROSPERO
|
|
|
3/9/21
|
Pagotto LEC, Pastore GP | PROSPERO
|
|
|
3/9/21
|
Isayev A, Veleiva N, Luljeta I, et al | PROSPERO
|
|
|
3/9/21
|
Kustanti CY, Yunitri N | PROSPERO
|
|
|
3/9/21
|
Jones J, Damery S, Phillips K, et al | PROSPERO
|
|
|
3/9/21
|
Zahair I, Wickham S, Rose T, et al | PROSPERO
|
|
|
3/9/21
|
Qi X, Ao G, Wang Y, et al | PROSPERO
|
|
|
3/9/21
|
Wei GX, Hao W, Ning L, et al | PROSPERO
|
|
|
3/9/21
|
Sonko I, Susanti HD | PROSPERO
|
|
|
3/8/21
|
Albuqueque J, Alexandrino VP, de Melo Silva CL, et al | PROSPERO
|
|
|
3/8/21
|
Langford B, So M, Leung V, et al | PROSPERO
|
|
|
3/8/21
|
Wei GX, Hao W, Nin L, et al | PROSPERO
|
|
|
3/8/21
|
Walsh S, Chowdhury A, Braithwaite V, et al. | medRxiv
Aim: To summarise observational evidence of the effect of school closures and school reopenings on SARS-CoV-2 community transmission. UPDATED
|
|
|
3/8/21
|
Ng KT, Chua EX, Teoh WY, et al | PROSPERO
|
|
|
3/8/21
|
Zhang S, Chen Zl | PROSPERO
|
|
|
3/8/21
|
Deng J, Zhou F, Hou W, et al | PROSPERO
|
|
|
3/8/21
|
Robinson R, Prakash V, Al Tamimi R, et al. | medRxiv
Aim: To estimate the association of remdesivir therapy compared to the usual care or placebo on all-cause mortality in hospitalized patients with COVID-19.
|
|
|
3/8/21
|
Feliciano-Alfonso JE, Buendia Rodriguez JA, et al | PROSPERO
|
|
|
3/8/21
|
Alharbi AO, Alzerwi NAN, Idrees B | PROSPERO
|
|
|
3/8/21
|
Wei GX, Hao W, Ning L, et al | PROSPERO
|
|
|
3/8/21
|
Parkinson E, Hooper L, Poland F, et al | PROSPERO
|
|
|
3/8/21
|
Carvalho AMS, Vale MS | PROSPERO
|
|
|
3/8/21
|
Zhang Y, Mei T, Chen Y, et al. | Medicine
|
|
|
3/8/21
|
Zhang Q, Lu H, Li F, et al. | Medicine
|
|
|
3/8/21
|
Samaan MC, Rajan R, Kshatriya M, et al | PROSPERO
|
|
|
3/8/21
|
Song G, Wei-Qiao, Yu X | PROSPERO
|
|
|
3/8/21
|
Clark R, Pearce-Smith N, Duval D | PROSPERO
|
|
|
3/5/21
|
Vaughan M, Trott M, Sapkota R, et al | PROSPERO
|
|
|
3/5/21
|
Köhler F, Wiegering A | PROSPERO
|
|
|
3/5/21
|
Uaprasert N, Tangcheewinsirkul N, Chiasakul T | PROSPERO
|
|
|
3/5/21
|
Wan Mohd Yunus WMA, Kauhanen L, Gyllenberg D, et al | PROSPERO
|
|
|
3/5/21
|
Ma S, Sun C, Qu G, et al | PROSPERO
|
|
|
3/5/21
|
Ruksakulpiwat S, Zhou W, Phianhasin L, et al | PROSPERO
|
|
|
3/5/21
|
Kirkovski A, Meyer-Katz G | PROSPERO
|
|
|
3/5/21
|
Kruse C, Atamosa L , Collins A, et al | PROSPERO
|
|
|
3/5/21
|
Nie X, Chen J, Ye F, et al. | Medicine
|
|
|
3/5/21
|
Griswold D, Gempeler A, Kolias A, et al. | BMJ Open
UPDATED
|
|
|
3/5/21
|
Li JW, Liu Y, Zhang ZQ, et al | PROSPERO
|
|
|
3/5/21
|
Zhan Q, Ni Y, Wang Y | PROSPERO
|
|
|
3/5/21
|
Han T, Dong T, Qu G, et al | PROSPERO
|
|
|
3/5/21
|
Kim DK, Kim JH | PROSPERO
|
|
|
3/4/21
|
Ost K, Duquesne L, Duguay C, et al. | medRxiv
Aim: To identify if and how equity has been considered in large-scale testing initiatives.
|
|
|
3/4/21
|
Mathevet I, Ost K, Traverson L, et al. | medRxiv
Aim: To determine if and how health inequities were included in the design of contact tracing interventions in epidemic settings.
|
|
|
3/4/21
|
Miguita L, Rossi NG | PROSPERO
|
|
|
3/4/21
|
Mohammed EE, Ragheb R, Ahmed W, et al | PROSPERO
|
|
|
3/4/21
|
Gary D, Mann J | PROSPERO
|
|
|
3/4/21
|
Sun X, Mazidi M, Kirwan R | Research Square
Aim: To study bidirectional relationships between weight gain, obesity and COVID-19 infection risk during the pandemic.
|
|
|
3/4/21
|
Yan Y, Ren Z, Lai L, et al | PROSPERO
|
|
|
3/4/21
|
Nyazika T, Ndalama M, Kitui S, et al | PROSPERO
|
|
|
3/4/21
|
Zakia H, Iskandar S | PROSPERO
|
|
|
3/4/21
|
Kim H, Kouyoumdjian F, Cavanagh A, et al | PROSPERO
|
|
|
3/3/21
|
Racine N, Eirich R, Cooke J, et al | PROSPERO
|
|
|
3/3/21
|
Costa FW, Pereira K, Roger A, et al | PROSPERO
|
|
|
3/3/21
|
Popal S, Edekunu G, Osamede A, et al | PROSPERO
|
|
|
3/3/21
|
Loader J, Taylor F, Sundström J | PROSPERO
|
|
|
3/3/21
|
Shao T, Hu Y, Yu W, et al | PROSPERO
|
|
|
3/2/21
|
Assessing the influence of misinformation and disinformation on health information seeking behaviors
McGowan B, Ekeigwe A | PROSPERO
|
|
|
3/2/21
|
Rehman Y, Sachdeca A, Ali P, et al | PROSPERO
|
|
|
3/2/21
|
de Souza Prazeres LP, dos Santos GGP, Veloso FCS, et al | PROSPERO
|
|
|
3/2/21
|
Shao T, Zhou D, Tang W | PROSPERO
|
|
|
3/2/21
|
Li Y, Liu M, Zhang Y, et al | PROSPERO
|
|
|
3/2/21
|
One Year of Evidence on Mental Health in the COVID-19 Crisis - A Systematic Review and Meta-Analysis
Chen X, Chen J, Zhang M, et al. | medRxiv
Aim: To review the evidence on the prevalence rate of mental health issues of the major population, including general population, general healthcare workers (HCWs), and frontline healthcare workers (HCWs), in China over one year of the COVID-19 crisis. UPDATED
|
|
|
3/2/21
|
Shi X, Xiu W, Gang W, et al | PROSPERO
|
|
|
3/2/21
|
Birtles R, Graziadio S, Mealing S, et al | PROSPERO
|